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ABSTRACT
Selective gene expression is crucial in maintaining the self-renewing and
differential potential of stem cells. Especially differentiation process requires a
constellation of proteins that regulate expression of genes necessary for differentiation
towards a specific lineage. Adipogenesis is a process of formation of mature fat cells
from precursor cells that is tightly regulated by a number of transcription factors and their
cofactors. Dysregulation in the process often leads to metabolic disorders, which is
common due to prevalence of obesity. Mediator is a large, evolutionarily conserved,
multi-subunit protein complex that functions as a transcriptional coactivator that
modulates gene expression by relaying signals from cell type-specific transcription
factors to RNA polymerase II. In humans, this complex consists of 30 subunits arranged
in four modules. One critical module of the Mediator complex is the kinase module
consisting of four subunits: MED12, MED13, CDK8, and CCNC. The kinase module
exists in variable association with the 26-subunit Mediator core and affects transcription
through phosphorylation of transcription factors and by controlling Mediator structure
and function. Many studies have shown the kinase module to be a key player in the
maintenance of stem cells that is distinct from a general role in transcription. Genetic
studies have revealed that dysregulation of this kinase subunit contributes to the
development of many human diseases. This research aims to demonstrate the importance
of the Mediator kinase module by examining their expression and interaction with key
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adipogenic regulators during adipogenesis. It is hypothesized that the kinase module
subunits have a role in adipogenesis of hASCs. As we look to use stem cells to
understand human development and treat human disease through both cell-based
therapies and tissue engineering, this research will address critical gaps in knowledge
related to the molecular mechanisms that control cell fate.
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CHAPTER 1
INTRODUCTION
*Note: Some parts of this chapter have been reproduced from the literature review
published in Stem Cells and Development. Straub J, Venigalla S, Newman JJ. Mediator's
Kinase Module: A Modular Regulator of Cell Fate. Stem Cells Dev. 2020
Dec;29(24):1535-1551. doi: 10.1089/scd.2020.0164. Epub 2020 Dec 3. PMID:
33161841.

Gene expression in eukaryotes is a complex process involving coordination
among numerous factors to regulate the expression of a specific gene. The intricate task
of regulating gene expression is primarily controlled during initiation of transcription
through binding of transcription factors and their cofactors to DNA elements located in
promoter-enhancer regions that then regulate RNA polymerase.6,7 This binding of
specific transcriptional regulatory proteins is responsible for development and
differentiation of cell types in response to hormones or growth factors. The interplay
between transcription factors and their cofactors with their target sites on the genome
serves as building blocks for the transcriptional network that governs cell proliferation,
cell fate, and cell state.8,9 Especially in stem cells, regulatory mechanisms support the
transcriptional framework and serve as governing agents of self-renewal and
pluripotency.10,11 A detailed understanding of the mechanisms controlling
pluripotency/multipotency and lineage commitment is essential in order to be able to use
stem cells for clinical applications.
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1.1

Stem Cells

Stem cells are undifferentiated cells which can give rise to specialized cells and
divide to produce more stem cells. Stem cells are found in multicellular organisms and
are characterized by their ability to self-renew and differentiate into different cells
(potency). The property of self-renewal in stem cells maintains the undifferentiated state
through many cycles of cell division.12 Potency is described as the potential to
differentiate into several types of cells. Stem cells can be totipotent, pluripotent,
multipotent, oligopotent, and unipotent (Figure 1-1). Totipotent stem cells can
differentiate into embryonic layers, which can make a complete living organism.
Pluripotent stem cells are derived from totipotent cells and can differentiate into nearly
all cells excluding extra embryonic tissue. Multipotent stem cells can differentiate into
only cell types of a specific lineage. Oligopotent stem cells can differentiate into only a
few types of cells. Unipotent stem cells can give rise to only cells of their own kind,
which have self-renewal capacity that distinguishes them from normal cells.13
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Figure 1-1: A hierarchal structure showing the differentiation potential of stem cells
based on their potency. Totipotent stem cells have the most differentiation potential while
unipotent cells have limited differentiation potential into tissues they are found in, and are
fully committed to becoming that tissue.1
Stem cells act as a repair system to aid in regeneration following tissue damage in
adults and are responsible for formation of embryonic layers and development of organs
in embryos. Today, stem cells are also used for treatment and prevention of disease in the
form of stem cell therapy; for example, bone marrow transplantation, which is widely
used in the treatment of patients with blood or bone marrow cancers, replaces a patient’s
diseased hematopoietic stem cells with a healthy donor’s cells.14
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1.1.1

Types of Stem Cells
Based upon the unique properties i.e., self-renewal and potency, stem cells are

categorized into two broad types: embryonic and adult stem cells. Embryonic stem (ES)
cells are found in the inner layer of the blastocyst of embryos and are pluripotent which
means they can give rise to the three germ layers: ectoderm, mesoderm, and endoderm,
that develop into organs during development.15 Adult stem cells, also called somatic stem
cells, are multipotent and are named after the origin of tissue: mesenchymal stem cells,
adipose-derived stem cells, endothelial stem cells, etc. Both embryonic and adult stem
cells can be used in regenerative medicine. Adult stem cells are also used in medical
therapies such as bone marrow transplantation. Unlike adult stem cells, ES cells remain a
questionable choice of source in regenerative medicine because of their ability for
unlimited expansion and pluripotency that are implicated in malignancy.16
Adult stem cells can give rise to all the cell types in which they originate from
and have the potential to regenerate the whole organ from a few cells. Depending upon
the types of cells they arise from, there are distinct types of adult stem cells with the most
well characterized and clinically useful being hematopoietic stem cells (HSCs),
mesenchymal stem cells (MSCs), and adipose-derived stem cells (ASCs). HSCs are
found in bone marrow and umbilical cord blood, and they can give rise to all blood cell
types. MSCs are multipotent somatic stem cells which can differentiate into bone,
muscle, cartilage, and adipose cells.17 ASCs, the focus of this research are multipotent
and can differentiate into cell types of multiple lineages, making them of great interest to
the field of regenerative medicine.18
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1.1.2

Adipose-derived Stem Cells (ASCs)
ASCs differentiate into cells of the adipogenic, chondrogenic, and osteogenic

lineages through a complex cascade of transcriptional and non-transcriptional pathways
(Figure 1-2). ASCs can be isolated, expanded and differentiated in vitro, through the
addition of specific chemicals and growth factors.19 It has been shown that adipose tissue
has properties suitable for tissue engineering and regenerative medicine as they are an
easily accessible, non-controversial stem cell source. When transplanted into wounded or
damaged sites, ASCs are able to interact with their adjacent cells leading to new
committed progenitor cells. They secrete cytokines, chemokines, exosomes, and miRNA
to restore tissue defects through stimulation of moelcular mechanisms involved in
angiogenesis, immunomodulation, cell proliferation, and cell differentiation.18,20
Altogether ASCs have raised significant interest for therapeutic applications in
regenerative medicine.

Figure 1-2: A graphical representation showing the differentiation potential of Adiposederived stem cells. Adipose-derived stem cells have the ability to differentiate into cells
of different lineages including adipogenic, chondrogenic, myogenic, and osteogenic.2
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To assure their self-renewal capacity, stem cells undergo symmetric and
asymmetric cell divisions. Symmetric division produces two identical cells with full selfrenewal ability, while asymmetric division gives rise to one stem cell and a progenitor
cell, which has limited self-renewal capacity.21 Progenitor cells ultimately can
differentiate into distinct cell types. The potency of stem cells can be identified by the
presence of surface markers and expression of specific transcription factors. Stem cells
depend on transcription factors to determine gene expression and cell fate. Self-renewal
and potency of the stem cells are maintained by a complex regulatory network, with
transcription factors, Oct4, Sox2, and Nanog, as major contributors.22 These transcription
factors, in association with some coactivators such as Mediator, ensure that transcription
is performed without any errors and that the right set of genes are activated or repressed
as needed.
1.2

The Mediator Complex

Eukaryotes, being far more complex than prokaryotes, owe their incredible
complexity to the regulation of gene expression provided, in large part, by the Mediator
complex.23 Mediator is a large, 1 million Dalton23 protein complex composed of between
20-30 subunits depending on species24, and is arranged in four distinct modules: head,
middle, tail, and kinase.25 Bioinformatic and biochemical analyses have identified most
of the H. sapiens Mediator subunits as similar in sequence, structure, and function to
those found in S. cerevisiae and D. melanogaster, indicating a high degree of sequence
conservation across eukaryotic species(Figure 1-3).26
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Figure 1-3: A graphical representation of structural differences between Saccharomyces
cerevisiae (yeast) and Homo sapiens (human) Mediator complex. Shared and highly
conserved subunits are shown in blue, whereas additional subunits that exist in humans
but not yeast are highlighted in orange. This includes subunits that can substitute for each
other in the kinase domain, including CDK8/CDK19, MED12/MED12L, and
MED13/MED13L.3
Mediator functions as a bridge-like adaptor to facilitate the interaction between
activators and RNAP II during activator-dependent transcription.27 Each module—and in
some cases individual subunits—of the H. sapiens Mediator complex has a unique role in
the regulation of transcription and interactions with the transcriptional machinery.24,28
Recent studies have indicated that Mediator is a key regulator and functional unit of
super-enhancers that are responsible for properly regulating cell type-specific gene
expression profiles.29,30 The roles of the head, middle and tail modules of the Mediator
complex have been largely defined within the context of directly regulating RNAP II
activity.24,27 The head module, together with the middle module, plays an essential role in
stabilizing the interaction of transcription factors and RNAP II during pre-initiation
complex (PIC) assembly on a cell type-specific promoter. The head module changes
conformation to accommodate the subunit organization that controls the Mediator-RNAP
II and Mediator-promoter interactions.31,32 While the head and middle modules bind
RNAP II and the PIC, the tail module interacts with transcription factors bound to
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peripheral gene regulatory elements.24,27 In addition, the tail module along with the kinase
module regulates the head and middle modules, whereas the core complex (head, middle,
and tail modules) represents the essential function of the Mediator complex.33 The kinase
module of the Mediator complex, composed of subunits MED12/L, MED13/L, CDK8/19,
and CCNC, is reversibly associated with the core complex34–36 and is perhaps the most
versatile and mysterious of all of Mediator’s modules.
1.2.1

Kinase Module
The Mediator complex exists in two forms: The Mediator complex with the

kinase module (30 subunits) and the core Mediator (26 subunits), which lacks the foursubunit kinase module. The 600 K Da kinase module is stable and able to exist and
function independently of the core Mediator complex and can transiently associate with
the core complex through MED13.8,37 The structural and functional aspects of the kinase
module, including information on paralogs of the kinase module subunits and the
importance of kinase activity in transcriptional regulation, is described below.
1.2.2

Structure and Function
A tightly organized network of both physical and functional subunit interactions

maintains the structural integrity of the kinase module. Detailed studies of this complex
structure have revealed the subunit organization within the kinase module, adding critical
insight into the mechanism of CDK8’s enzymatic activity. Specifically, early
electromagnetic analysis in S. cerevisiae showed the kinase module structure having two
bent protruding ends, identified as CDK8-CCNC, MED13, and a central globular protein,
MED12. This model correlated with the previously observed human kinase module

11
structure, with both models confirming the connection of the kinase module to the
Mediator core through MED13.37
The association of the kinase module through MED13/MED13L allows for the
adoption of different conformations and reversible interactions not just with the core
Mediator but with other factors involved in transcription and cell state regulation.38 In
addition, physical interactions between kinase module subunits and the core Mediator
leads to the adoption of different complex conformations, which also plays a role in
activating CDK8 kinase activity. Compiling data from different studies, it has been
shown that CDK8 kinase activity is activated through a series of sequential steps: the first
is the binding of CDK8 to its cyclin partner, Cyclin C (CCNC), resulting in partial
activation of CDK8. This is then followed by the binding of MED12 which results in the
final necessary conformational change.39,40 Biochemical studies revealed that CCNC
possesses a surface groove that acts as a MED12 docking site. Mutations in either CCNC
or the MED12 interface located at the N-terminal of MED12 leads to the dissociation of
CCNC-CDK8 from the core Mediator complex followed by impaired kinase activity of
CDK8.41 These findings suggest that the MED12-CCNC binding interface serves as an
anchor that also activates CCNC-CDK8.
1.2.3

Kinase Module Paralogs
Although highly conserved as a complete complex, the kinase module in

vertebrates is unique and more complex when compared to the core complex as three of
the four subunits have paralogs. CDK8 can be replaced by CDK19, MED12 can be
replaced by MED12L, and MED13 can be replaced by MED13L.42,43 The replacement of
these subunits by their paralogs is mutually exclusive, meaning that the kinase module
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can possess either MED12 or MED12L but not both subunits simultaneously, leading to
eight different forms of the kinase module subunits (Figure 1-4).44

Figure 1-4: A graphical representation of mutually exclusive paralogs of subunits from
the Mediator kinase domain. These paralogs, CDK19, MED12L, and MED13L, are
replaced by CDK8, MED12, and MED13, respectively, under specific conditions,
although the full details of how and why remain unknown.3

CDK19, the homolog of CDK8, shares a 91% sequence homology with CDK8.
There is an especially high degree of sequence conservation in the kinase activity domain
and cyclin binding domain, with more divergence in the C-terminal sequence. The high
degree of similarity suggests that CDK8 and CDK19 have overlapping functions and that
one may be able to compensate for loss or absence of the other as it relates to kinase
activity. For example, isolation and purification of CDK8/CDK19 interacting proteins
demonstrates that both CDK19 and CDK8 interact with PRMT5 during repression of
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transcription in HeLa cells. However, given that the tail portion of CDK8/CDK19
interacts with transcription factors and cofactors, the difference in the C-terminal
sequence suggests that CDK8 and CDK19 more likely regulate different transcriptional
programs.42,45 Supporting this is the fact that CDK8 and CDK19 are differentially
expressed across tissues, with CDK19 expression restricted to prostate, testis, thymus,
and salivary glands, while CDK8 is expressed more ubiquitously across tissues.46
Homology studies reveal that MED12 and MED12L share a 67% gene sequence
identity, sharing two of four protein domains: PQL (proline/glutamine/leucine-rich) and
OPA (C-terminal opposite paired domain). Interestingly, according to the human protein
atlas, after analyzing approximately 37 human tissue samples, MED12L is found to be
most highly expressed in the brain while MED12 is expressed ubiquitously in all
tissues.47,48 Though they only share similarity in two of the domains, there does appear to
be functional redundancy between MED12 and MED12L. For example, a study by Vogl
et al. suggests MED12 and MED12L have the same binding sites for SOX10, which is an
essential component of the transcriptional network that regulates the development and
terminal differentiation of myelinating glia. From a series of pull-down experiments of
MED12/MED12L and SOX10 proteins, it is evident that the C-terminal region of both
MED12 and MED12L interact with SOX10. This discovery led to the assumption that
both proteins have the same function in the regulation of transcription during the
differentiation of myelinating glia.49 However, there is currently little research in this
area, making it difficult to evaluate the complete functional redundancy between MED12
and MED12L.
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Finally, MED13L shares a 51% sequence similarity to MED1350 and they both
serve to link the kinase module to core Mediator by associating with middle module
subunits, MED14 and MED19.51 Notably, this interaction of MED13/MED13L with core
Mediator is regulated by SCF-FBW7 ubiquitin ligase through the proteasomal
degradation of MED13/MED13L. Immunoprecipitation and in vitro ubiquitylation assays
reveal that MED13/MED13L are directly ubiquitylated by SCF-FBW7 in vitro.34 This
degradation of MED13/MED13L prevents the kinase module from associating with the
core complex suggesting that MED13/MED13L serves as an anchor for the kinase
module. Interestingly, MED13L, but not MED13, associates with MED26, indicating
there may be unique functions for each subunit. When co-purified, MED13L is
accompanied by a high abundance of MED26; however, MED13L is not present in
MED26 isolations. This association is found to be specific to MED13L, as the same set
of pull-down assays does not show a robust association between MED13 and MED26.42
According to the human protein atlas, MED13L is primarily expressed in heart and brain
while MED13 is expressed in all human tissues. More recent evidence supports previous
studies indicating that mutations in med13l are associated with neurodevelopmental
defects and heart diseases.52,53 Knockdown and conditional knockout studies of MED13
in murine zygotes suggest that MED13L can partially substitute for MED13 and function
during the development of embryo.54 This study demonstrates that MED13 is required for
both transcriptional activation and repression during zygote genome activation, as
demonstrated through the up- and downregulated transcripts observed in MED13knockdown embryos. Furthermore, med13 knockout embryos showed arrested
development post-implantation. MED13L compensated for MED13 function during the
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OET (oocyte to embryo transition) enough to support embryo development to the
blastocyst stage during preimplantation in med13 knockout murine zygotes. Clearly, the
functional compensation of MED13 by MED13L is limited in context, as evident by its
lack of compensation during post-implantation development and other studies showing
mutations of MED13/MED13L that lead to disruptions of cellular functions resulting in
respective disorders.55,56
Together, studies surrounding the kinase module and each of the seven subunits
indicate that the kinase module of the Mediator complex can present itself in many forms
by changing its subunit configuration to diversify its function. Although it appears that
there is some amount of functional overlap between paralogs, there is no complete
functional redundancy for any of these kinase module subunits. Some of these paralogs
may in fact play different roles in development and cell-type specific transcription
programs. In addition, individual genetic mutations of kinase subunits leads to embryonic
lethality in mice and many human disorders with clear developmental disruptions.54,57–59
In addition, research to date excludes the possibility of complete functional redundancy
among the paralogs as they failed to substitute for their paralogous subunits (except for
the partial functional compensation of MED13 by MED13L in murine zygote
development as described in MED13 paralog section) when the other is genetically
disrupted. The mutually exclusive nature, the unique expression profiles, and the relative
functional contribution of each kinase module paralog still requires more thorough
investigation to understand the structural interactions and functional relationships within
the kinase module and what role each subunit plays in human development and disease.
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1.2.4

Kinase Module and Human Diseases
The Mediator kinase module is a critical component of the transcriptional

machinery required for proper regulation of gene expression and lineage commitment of
cells during development and tissue differentiation.23,27,60 Kinase module subunits, as part
of the Mediator complex, have been linked to many key developmental and oncogenic
signaling pathways including Wnt, mTORC1, EGF, SHH, and Notch.26,30,58,61 Alterations
of individual subunits of the kinase module have been associated with developmental
defects and diseases including Lujan syndrome, schizophrenia, breast and uterine
cancers, and cardiovascular diseases.62 Studies have found that the kinase module
subunits are direct targets of genetic alteration in human tumors and specifically,
MED12, the largest subunit of the kinase module, has been consistently implicated in
many female cancers and cognitive developmental conditions. Research indicates that it
is the role of MED12 in regulating the kinase activity of the module that leads to a
number of these outcomes.63 Specific roles for each of the kinase module subunits in
development and disease can be found in Table 1-1.
Table 1-1: Currently known roles for the Mediator kinase subunits in development or
disease. Most cancers noted in this table were previously compiled and reviewed by
Clark et al. in 2015.5
Subunit

Role and diseases

Cyclin C

Multiple deletions associated with T-cell acute lymphoblastic
leukemia; function as a tumor suppressor64
Deletion associated with osteosarcoma; function as an inhibitor of cell
growth65
Regulation of adipogenesis66
G0 to G1 transition in CD34+ cord blood cells67

CDK8

Phosphorylation of TFIIH to activate transcription68
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Phosphorylation of E2F to activate transcription69
Phosphorylation of RNA Pol II C-terminal domain to repress
transcription70
Maintenance of ESC pluripotency mediated by MYC protein71
Colorectal cancer oncogenesis72,73
Melanoma oncogenesis73
Breast tumorigenesis38
Endometrial cancer tumor suppression74
CDK19

Upregulated in prostate cancer75
Intellectual disability76

MED12

Designated a cancer driver gene77
Uterine leiomyoma oncogenesis41,63,78–80
Breast fibroadenoma oncogenesis and phyllodes tumorigenesis63,81,82
Prostate cancer oncogenesis83,84
Interaction with NANOG and SOX2 C-terminals to regulate ESC
pluripotency85
Interaction with Wnt/β-catenin to recruit core Mediator to target
genes58
Interaction with PRC1 to repress differentiation genes during
pluripotency86
Super-enhancer-associated co-activator57
Maintenance of HSC viability57
FG syndrome87,88
Lujan syndrome89
Ohdo syndrome90
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MED12L Designated a cancer driver gene91
MED13

Neurodevelopmental disease53
Breast cancer oncogenesis92
Regulation of early embryogenesis93
Interaction with Smad7 to regulate myogenesis94

MED13L Congenital heart defects50,56,95

1.2.5

Kinase Module in Transcriptional Control
The kinase module functions as both an activator and repressor of gene

transcription, making the study of the module that much more complicated. Initial
functional studies revealed a repressive function for the kinase module in S. cerevisiae
where the Mediator core, together with the kinase module, repressed transcription and the
Mediator core alone enhanced activator-dependent transcription.96 Early electromagnetic
structural, and subsequent functional studies in human HeLa cells showed that the kinase
module repressed transcription by preventing the binding of RNAP II to Mediator thereby
blocking the formation of the PIC-scaffold complex. This inhibition was achieved via
multiple mechanisms, including kinase-independent regulation of Mediator-RNAP II
interaction39, kinase-dependent inactivation of TFIIH by phosphorylation96, and gene
silencing through the recruitment of histone methyl-transferases.38 Later, biochemical and
molecular studies supported the view that the kinase module has a context dependent role
in both gene repression and activation.29,97 It now appears that when the Mediator core is
absent, the kinase module acts to inhibit core Mediator function within the pre-initiation
complex (PIC).38,97 Furthermore, the kinase module appears to mediate transcriptional
activation through ncRNA-a (noncoding RNA-a, a class of ncRNAs which activate
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neighboring genes) by interacting with MED12 and chromatin.98 Finally, a new role for
the kinase module in the regulation of transcription elongation has been reported where
the kinase module appears to coordinate with positive transcription elongation factor b
(P-TEFb) by regulating its kinase activity. ChIP analysis and genome occupancy profiles
of elongation factors in human cells indicate that CDK8 orchestrates key events in the
formation of a functional elongation complex. CDK8 is required for RNAP II dependent
elongation by phosphorylating the C-terminal domain of RNAP II as they demonstrate
that RNAP II elongation is impaired upon knockdown of CDK8.99 This study also
suggests that the kinase module may facilitate the interaction of P-TEFb with core
Mediator to regulate RNAP II phosphorylation and transcription elongation. These
studies represent a marked advance in our understanding of how the kinase module acts
to both repress and promote gene expression, while also revealing additional questions
about the role the kinase module has as part of the core Mediator complex in regulating
transcription.
Although the precise mechanism that regulates the reversible association of the
kinase module with core Mediator is not clearly understood, a few studies offer some
insight into why the regulatory association of the kinase module with core Mediator
occurs. Initial clues were provided by studies in yeast suggesting that the reversible
association between the kinase module and core Mediator existed as way of regulating
the output of signaling-dependent transcription. Similarly, later studies in mammals
suggest that specific cellular signals and signaling pathways regulate Mediator-kinase
module association. For example, an in vivo study by Mo et al. in human HeLa cells
showed that in response to Ras signaling, the repressed promoter of the C/EBPβ is kinase
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module-bound whereas, upon activation, the kinase module is lost.35 Another study by
Pavri et al. demonstrated the switch from inactive to active Mediator executed by PARP1 during retinoic acid (RA)-induced gene expression in vivo. ChIP analysis of promoter
occupancy in PARP-1 present and absent cells shows that in the absence of PARP-1,
Mediator did not attain its active conformation (accompanied by loss of kinase module)
upon RA induction as evidenced by the retention of CDK8 after RA treatment.36
Although these studies do not prove the exact mechanism for what triggers the kinase
module to dissociate from the core, they do suggest that the kinase-containing Mediator
complex requires an interaction with other factors in order to detach from the kinase
module and adopt the conformation required to facilitate transcriptional activation.
Indeed, Davis et al. demonstrated mechanistic evidence of kinase module dissociation
involving SCF-FBW7 ubiquitin ligase mediated proteasomal degradation of
MED13/MED13L, which anchors the kinase module to core Mediator.34 A recent study
by Youn et al. also demonstrated that the Mediator complex in mouse liver undergoes
dynamic physiologic regulation through nutrient signaling-dependent downregulation of
the kinase module to core Mediator. This dissociation and degradation of the kinase
module is induced by SCF-FBW7 E3 ligase.100
Finally, the Mediator kinase module has been implicated as a gene regulator in
physiological processes from development and differentiation to the maintenance of cell
fate and function. Several genetic studies have revealed critical roles for kinase subunits
in regulating signal-dependent gene expression during development.58,81,101 In mice,
kinase module subunits are found to be critical in early development, as evident by
embryonic lethality resulting from mutations in kinase subunits. For example, embryo
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implantation failure is observed when CDK8 is inactivated through gene trap insertions,
suggesting that CDK8 is necessary for preimplantation of mouse embryos.59 CCNC
knockout murine embryos failed to survive past implantation due to severe
developmental retardation and an underdeveloped placental layer.64 MED12 mutant and
knockout embryos failed to survive later embryonic stages as they suffered from acute
defects in developmental processes including neural tube closure and heart formation.55
Several studies show that these developmental disruptions arise from defects in key
developmental signaling pathways, including Wnt, Notch, mTORC1, and TGFβ. The
kinase module subunits are found to be involved in expression of signaling pathway
target genes and when mutated, lose their ability to activate or repress expression of
required target genes for respective signaling pathways, leading to impaired responses of
signaling pathways as illustrated by a growing number of developmental disorders. For
example, loss of CDK8 in murine embryos is shown to disrupt Wnt target gene
expression.101 Mutant MED12 murine embryos showed aberrant Wnt/β-catenin target
gene expression, indicating that MED12 is essential for Wnt signaling during
embryogenesis where MED12 mutant embryos recapitulated phenotypes similar to those
observed in the absence of β-catenin.55 Recently, CDK8/CDK19 has been shown to have
a role in negatively regulating Notch 1 signaling, a developmental pathway which
regulates self-renewal and differentiation in several cell types including stem cells.64
Kinase subunits have also been linked to TGFβ, a developmental signaling pathway
which regulates cell proliferation, differentiation, cell fate, and apoptosis. CDK8-CCNC
plays a critical role in regulation of SMADS in TGFβ driven transcriptional responses by
limiting the SMAD2/3-dependent induction of mesodermal cell fate in response to TGFβ
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signaling.102 Recently, a study by Youn et al. demonstrated that when mice were fasted
and refed, the kinase module dissociated and degraded upon nutrient activation of
mTORC1 in mouse livers. This dissociation and degradation of the kinase module is
necessary for the induction of lipogenic gene expression because
genetic/pharmacological inhibition of mTORC1 in the fed state restores the kinase
module suggesting that the kinase module plays a role in repressing lipogenic gene
expression. In addition, genetically insulin resistant and obese mice in the fasted state
showed elevated levels of lipogenic gene expression and loss of the kinase module was
reversed following mTORC1 inhibition.61 In agreement with these studies, the kinase
module has been involved as the terminal factor of cell signaling pathways due to its
representation as a final and functional target for transcription factors. Together, these
studies imply a highly targeted role of individual Mediator subunits in the regulation of
cell state and lineage commitment through the regulation of developmental signaling
pathways.
1.2.6

Kinase Activity
One of the most important and highly conserved functions of the kinase module is

its kinase activity. The best characterized of these activities is the kinase module’s
phosphorylation of the C-terminal domain of RNAP II during transcription initiation,
elongation, and RNA processing.24 Human CDK8 appears to negatively regulate
transcription by phosphorylating TFIIH96, while inhibition of CDK8 kinase activity
suppresses the RNAP II CTD phosphorylation thereby preventing elongation of
transcription.103 Despite the requirement for CDK8 and CCNC to interact and bring the
kinase module together, the CDK8-CCNC interaction is not sufficient for CDK8 kinase
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activity. In the past two years, a series of studies by two different labs have provided
evidence that MED12 is required for CDK8 kinase activity.94,104 With a combination of
Hi-C and cryo-EM studies along with knockdown studies in murine embryonic stem
cells, MED12 knockdown cells showed acute depletion of Mediator and RNAP II,
indicating that MED12 is required for proper phosphorylation of RNAP II. Another
recent study by Klatt et al. described the binding location of MED12 and CDK8-CCNC
dimer providing insight into activation of CDK8 by MED12. In vitro biochemical and in
vivo studies together with cross-linking coupled with mass spectroscopy, demonstrated
that the N-terminal of MED12 wraps around CDK8 at its T-loop to form an activation
helix, which activates the enzymatic activity of CDK8.104 With MED12 now known to
activate CDK8 as a kinase, the association of MED12 with the CDK8-CCNC dimer
provides a critical element of regulation and prevents uncontrolled and inappropriate
substrate targeting.
Overall, the genetic and biochemical analysis of the kinase module is consistent
with the functional studies indicating a role for this unique module in both gene
activation and repression. The kinase activity of CDK8 is required for activatordependent transcription and has been shown to direct multiple steps in transcription
including initiation, elongation, and re-initiation. Although several studies have begun to
shed light on the signaling and mechanistic role for the kinase module and Mediator core,
there is still much to be explored. Involvement of kinase subunits in many physiological
processes and pathways indicates the complexity and the functional implications of the
kinase module subunits either individually or as a complete structure. The significant
functional involvement of the Mediator kinase module in regulating aspects of
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transcription has a significant impact on human development as illustrated by an
increasing number of diseases and developmental disorders that have been associated
with Mediator subunit mutations.
1.3

Kinase Module and Stem cells

Gene regulation is tightly controlled in order to ensure proper transcription for
healthy organismal development. Aberrant gene expression is implicated in a multitude
of developmental defects and diseases and would be more rampant if not for the highly
specialized, complex method of cell type-specific transcriptional control.105,106 The
unique properties of stem cells to both self-renew and differentiate under controlled
laboratory conditions allows for the effects and functional characterization of deliberate
perturbations in the regulation of gene expression.13 This includes altering the function
and expression of the general transcription factors (GTFs) that assemble the transcription
pre-initiation complex on gene promoters, activators and repressors that bind to gene
regulatory elements located upstream or downstream of promoters, and the essential coactivator of cell type-specific genes like the Mediator complex. The fate of any stem cell
is ultimately determined by regulating the transcription of specific genes, a feature
largely facilitated by the Mediator complex. Stem cell self-renewal and the role of the
Mediator complex kinase module in this process, followed by the kinase module’s
regulation of differentiation down the various possible lineages is described below.
1.3.1

Kinase Module in Self-renewal and Differentiation of Stem Cells
Self-renewal is the process by which stem cells replicate themselves to maintain a

stable population of undifferentiated clones. For individual stem cells, self-renewal and
differentiation are mutually exclusive in that lineage commitment down a differentiation
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pathway which alters a stem cell’s gene expression profile away from self-renewal
permanently. If a stem cell is not self-renewing, it is differentiating, and vice versa107—
until the stem cell reaches quiescence, temporarily halting further self-renewal.108 Work
by Miyata et al. revealed that CCNC plays a role in maintaining expression of CD34
levels in human cord blood CD34+ cells by keeping the cells in G0 phase.76 CDK8 has
also been shown to play a role in stem cell self-renewal where knockdown of CDK8 in
murine ESCs resulted in a loss of ESC pluripotency.80 Furthermore, knockdown of
MED12 in murine ESCs also resulted in loss of pluripotency.114 Med12 is also shown to
be critical for maintaining HSC viability in murine ESCs where MED12 knockout
revealed the inability of murine HSCs to form colonies highlighting a failure in selfrenewal.33 Finally, out of all Mediator subunits, MED13 was the most highly translated
Mediator subunit during oocyte maturation with MED13L and MED12L ranking at
second and third, respectively. RNA-seq analysis revealed that the knockdown of
MED13 results in 1201 upregulated and 2203 downregulated genes. RNA processing,
cell cycle, transcription, protein catabolism, and chromatin modification were among the
categories of the downregulated genes discovered during GO analysis.54 Given that these
sets of genes are important for determining cell state, these results point toward the
Mediator kinase module as an integral cell state regulator.
Differentiation is the process by which a stem cell alters its transcription program
in response to the external environment and internal regulation to commit to one of its
many potential lineages. In normal, healthy stem cells, differentiation is a permanent
epigenetic transformation that, once started, causes a stem cell to lose its potency and
self-renewal capacity while gaining specialized forms and functions important to the
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operation of tissues and organs. This research investigates the lineage commitment
especially adipogenic lineage and the role of kinase module in supporting the critical role
of Mediator in directing cell fate and need for continued research in this area.
1.3.2

Kinase Module in Adipogenesis
Work by Song et al. involved screening adipocytes with shRNA libraries to

identify genes whose expression was altered during adipogenesis. CCNC and CDK19
were downregulated while CDK8 was upregulated during adipogenesis. CCNC and
CDK19 expression in brown adipose tissue of 2-year-old mice was down to 25% of the
expression levels present in 3-month-old mice. Conversely, CDK8 expression was twice
as high in brown adipose tissue of older mice when compared to younger mice. Since
brown adipose tissue is responsible for producing heat, groups of mice were exposed to
either 4°C or 22°C conditions. The transcription levels of ccnc, cdk8, and cdk19 mRNA
were determined to be unaffected by these differences in temperature; however, CCNC
and CDK19 protein expression fell slightly while CDK8 rose in the 4°C group compared
to 22°C. After performing siRNA knockdown of ccnc, the expression of adipogenesis
markers including PPARΓ, FABP4, and CEBPA fell during the first 2 days of
adipogenesis, but expression of these genes increased after 5 days to the levels in the
control group. After switching to an inducible knockout system for CCNC, cells
undergoing CCNC knockout did not undergo adipogenesis and did not express the
previously tested adipogenic markers as well as a host of other genes associated with
brown adipose tissue, mitochondria, and lipogenesis. Retroviruses expressing CCNC only
partly rescued adipogenesis in CCNC knockout cells but did not improve adipogenesis in
cells unaffected by CCNC knockout. The most down regulated pathway in the absence of
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CCNC was the PPAR pathway, a master regulator of adipogenesis. PPARΓ-2
overexpression rescued both lipid vesicle formation and adipogenic marker expression in
CCNC knockout cells, showing that PPARΓ’s activity does not depend on CCNC.
C/EBPα, a co-regulator of adipogenesis along with PPARΓ, could not rescue
adipogenesis upon overexpression in CCNC knockout cells. Due to C/EBPα being an
important regulator of white adipose tissue, siRNA knockdown of CCNC was also
performed in 3T3-L1 cells, revealing a similar decrease in lipid accumulation and
adipogenic marker expression as was seen in brown adipose tissue.66 In summary, CCNC
regulates adipogenesis by interacting with C/EBPα.
1.4

Conclusion

It’s been three decades since the discovery of the Mediator complex, expanding
our understanding of cell complexity which led to a multitude of further questions.
Because of that, we now know how Mediator functions to regulate cell type-specific gene
transcription. The kinase module has expanded the complexity of this regulatory
relationship given its transient nature, and its certain because of the kinase module’s
subunit CDK8/19 possessing kinase activity. It is understood that each kinase module
subunit plays an integral role in the modules over all stability, thereby enhancing its
regulatory and kinase activity. Unfortunately, mutations in these subunits have been
implicated in developmental disorders and diseases, including many cancers, wherein lies
the importance of proper kinase module functioning to maintain healthy development and
cell fate determination.
Despite what we have learned, we still do not have a complete understanding of
how the kinase module interacts with nuclear machinery and signaling molecules to drive
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cell state into a particular direction of cell proliferation or to differentiate into a particular
lineage while avoiding oncogenic state. A large focus has been on MED12, warranted
due to its importance in oncogenesis and development. The web of interactions between
Mediator kinase module, the various transcription factors, and the magnitude of signaling
molecules is falling into place piece-by-piece but work is far from finished. The benefits
will likely extend beyond molecular biology, stem cell biology, and biochemistry and
into clinical application. Given a more complete understanding of cell state regulation,
we may one day see the efforts of this research pay off in the form of regenerative
medicine involving stem cell therapies that are tailorable to individual patients, therefore
maximizing patient benefit.

CHAPTER 2
REGULATION OF KINASE MODULE SUBUNIT EXPRESSION
AND INTERACTION IN MOUSE ADIPOSE TISSUE

2.1

Introduction

According to the WHO more than 650 million people in the world are obese
and the prevalence of obesity is approximately 42.4% in the United States by 2018.109 In
2000, there were an estimated 300 million obese adults worldwide and the number of
obese adults had doubled by 2018. Obesity is a global epidemic in all age groups and in
both developed and developing countries, placing a large burden on the health care
system and economy. Obesity carries serious health implications due to its associated
disorders including insulin resistance, type 2 diabetes mellitus (T2D), cardiovascular
diseases, metabolic disorders, and some types of cancer (Figure 2-1).110,111 Obesity is
characterized by excess body fat accumulation, to the extent that health is impaired. The
amount and distribution of excess fat accumulation is associated with a greater risk of
disability or premature death. The additional energy that results from caloric excess is
stored as lipids in adipose tissue and may accumulate in other metabolic organs such as
liver and skeletal muscle.112 That increased amount of lipid significantly alters normal
metabolism and creates an environment that chronically transmits a signal of nutrient
excess to the cell. As a result, signaling cascades that drive glucose uptake, cell growth,
cell proliferation, and angiogenesis are activated. An increase in adipose tissue associated
29
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with obesity correlates with an increase in levels of leptin and with reduction in levels of
adiponectin. Leptin and adiponectin are adipokines, a set of cytokines secreted by adipose
tissue that have pleiotropic effects on metabolism, cellular signaling, and inflammatory
pathways.113 Leptin regulates appetite and energy balance through activation of multiple
signaling cascades including the PI3K, MAPK, mTOR, and JAK/STAT pathways.
Adiponectin balances many of the effects of leptin by activating AMP, which has a
variety of cellular effects including induction of cell cycle arrest and inhibition of mTOR
activity. This opposing effect of leptin and adiponectin and the change in ratio of the two
adipokines is a critical change linked to obesity.114,115

Figure 2-1: A pictorial representation of molecular disturbances resulting due to obesity.
Obesity causes dysregulation of metabolic gene expression leading to disorders. Increase
in insulin, blood glucose, lipid peroxidation causes oxidative stress and inflammation
which leads to dysregulation of genes and gene expression causing metabolic disorders.
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In mammals, adipose cells exist as three types: brown, white, and beige. Brown
adipose tissue (BAT) specializes in heat production by exerting its thermogenic function
mainly in newborn babies. BAT is present in the interscapular region and posteriorly, and
can transform into white adipose tissue (WAT).116 Beige adipose tissue is believed to
originate from white adipocytes trans-differentiation within the same cellular lineage and
is still under investigation to uncover additional properties. Genetically, beige adipocytes
are found to have an intermediate behavior between brown and white adipose tissues,
where they can store the excess energy in the form of lipids and when stimulated
dissipate energy to produce heat.116–118 WAT is the most abundant adipose tissue and is
responsible for lipid storage in the form of triglycerides. Most WAT is distributed
throughout the body in subcutaneous and visceral depots and their characteristics are
important for differential susceptibility to metabolic diseases. Subcutaneous WAT is
located beneath the skin and has been associated with protective metabolic diseases;
whereas visceral tissue surrounds the vital organs and is contained within the gonadal,
perirenal, retroperitoneal, and pericardial depots (Figure 2-2), linked to metabolic
disorders including T2DM and cardiovascular disease.114,119,120
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Figure 2-2: A graphical representation showing different adipose tissue depots in mice
(left) and humans (right). Showing are white and brown adipose tissue deposited in
different places of mice and human bodies. White adipose tissue is situated either
subcutaneous or visceral regions of the body of an organism.4

The expansion of adipose tissues through hypertrophy of mature adipocytes and
differentiation of preadipocytes through a process called adipogenesis to store excess
triacylglycerols often leads to obesity. Impairment in adipogenesis leads to ectopic
deposition of fat in several organs including skeletal muscles, liver, and kidneys,
characterized by impaired secretion of various adipokines, and resulting in insulin
resistance and an increased risk for type2 diabetes.4,115 The process of transforming
preadipocytes into adipocytes is regulated by an elaborate network of transcription
factors that coordinate the expression of hundreds of proteins responsible for establishing
the mature fat cell phenotype. The two main factors of this network are PPARγ and
C/EBPα, which oversee the entire terminal differentiation process. PPARγ in particular is
considered the master regulator of adipogenesis.121–123 When an adipogenic program is
activated, the stimulated cells reenter the cell cycle and progress through clonal
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expansion, where the cells express specific adipogenic transcription factors and cell-cycle
regulators that facilitate the expression of PPARγ and C/EBPα . These adipogeniccommitted cells now undergo terminal differentiation manifested by production of lipid
droplets and expression of various metabolic programs characteristic of mature fat cells.
Emphasis on research to understand the transcriptional processes controlling the
conversion of precursor cells into fully functional adipocytes has shown that various
coactivators and corepressors control the activity of the adipogenic transcription factors
that induce a well-defined component of the adipogenic process.122 A number of factors
enhance adipogenesis and serve as molecular switches in controlling the fate of the
progenitors. One such crucial coactivator that facilitates the communication of
adipogenic transcription factors with the transcriptional machinery is the Mediator
complex.124
Mediator is a multi-subunit protein complex that functions as a bridge between
RNA Polymerase II and cell-type specific transcription factors. The Mediator complex is
conserved in all eukaryotes from yeast to humans, consisting of 25-31 subunits and
comprised of four modules: head, middle, tail and kinase domain.125–127 Mediator controls
and coordinates multiple steps in transcription including initiation and elongation and has
roles in gene activation and repression. It plays a key role in both activator dependent and
activator independent transcription. In activator independent transcription it controls the
formation of the initiation complex.128–131 Based on previous findings, mutations or
alterations to the Mediator complex also has a role in many types of cancer, as well as
developmental, neurological, and metabolic disorders.132 Different Mediator subunits
seem to control distinct types and stages of cancer through specific signaling pathways.
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In studying the roles of subunits of the Mediator complex it is known that one or more
subunits are involved in developmental processes. Knockout studies of the Mediator
complex in mice revealed the involvement of its subunits in developmental processes
including chondrogenesis, adipogenesis, cardiovascular development, and differentiation
of neuron, smooth muscle, luminal cell, and keratinocyte.30,133 Data from previous studies
indicate interaction of subunits with specific transcription factors, which regulate
transcription of genes involved in development and cell differentiation.134,135
Recently, it has been reported that the kinase module is dissociated and degraded
through a nutrient-stimulated mTORC1-dependent regulation in mouse liver.100 However,
it is unclear whether the kinase module expression is regulated in adipose tissue under
nutrient-regulated physiological state. In this study, it is demonstrated that the kinase
subunits in certain mouse adipose tissue depots undergo physiological downregulation of
the entire kinase module. In addition, the interaction of MED12 and CDK8 with different
adipogenic regulators reveals the dynamic possible ability of these subunits in regulating
the initiation, progression, and maintenance of adipogenic lineage.
2.2
2.2.1

Materials and Methods

Animal Studies
14-week-old female mice (strain:C57BL6/J) were used for fasting and

feeding experiments. Mice were provided 5015 mouse chow. For fasting and feeding
experiments, the fasting group (n=3) were fasted overnight for 14 hrs and sacrificed the
next morning, whereas the fed group (n=3) were provided with food 4 hrs after 14 hrs of
overnight fasting and were sacrificed after feeding.
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2.2.2

Protein Extraction and Immunoblotting
Fresh mouse fat pad depot tissues were cut and frozen immediately in liquid

nitrogen. The tissues were homogenized in IP buffer that contained 10 mM Tris (pH 7.4),
150 mM NaCl, 1mM EGTA, 1 mM EDTA, 1% Triton X-100, and 0.5% IGEPAL CA630 for 5-10 seconds and immediately placed on ice. A mixture of protease inhibitors (1
mM PMSF, 1 µM pepstatin, 50 trypsin inhibitory milliunits of aprotinin, 10 µM
leupeptin, 1 mM 1, 10-phenanthroline) and phosphatase inhibitors (100 µM sodium
fluoride and 0.2 mM sodium vanadate) were added to IP buffer. After centrifugation at
20,000 XG for 20 min at 4C, the resulting supernatants were used for immunoblotting.
Total fat depots tissue lysates were prepared using the IP lysis buffer with freshly added
protease inhibitors and phosphatase inhibitors. Protein was quantified using BCA assay
(Sigma-Aldrich cat# BCA1). Protein samples were separated on 5% and 12% SDS gels
(acrylamide Cat # EC-890, National Diagnostics) and transferred to nitrocellulose
membrane (Cat# 162-0115). Western blots were performed to detect Mediator subunits
and adipogenic factors (Table 2-1).
Table 2-1. An overview of antibodies used in western blotting analysis.
Antibody

Dilution

Company

Catalog number

MED12

1:1000

Bethyl Laboratories

A301-774A-M

MED13

1:1000

Bethyl Laboratories

A301-278A-M

CDK8

1:1000

Bethyl Laboratories

A302-501A-M

CCNC

1:1000

Bethyl Laboratories

A301-989A-M

Tubulin

1:2000

Cell Signaling

2144S

Adiponectin

1:1000

Thermofisher

PA1-054
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PPARγ

1:100

CEBPα

1:1000

SREBP1c

1:1000

STAT5A

1:1000

Goat Anti-mouse

1:10,000

Goat Anti-Rabbit

1:10,000

2.2.3

Santa Cruz
Biotechnology
Abcam

SC-7273

Santa Cruz
Biotechnology
Abcam

SC-365513

Jackson
Immunoresearch
Jackson
Immunoresearch

115-035-071

Ab15048

Ab32043

115-035-003

Immunoprecipitation Assay
3T3L1 mouse preadipocytes (originally obtained from Howard Green lab at

Harvard Medical School) were cultured using standard cell culture medium (DMEMSigma-Aldrich cat# D5030 with 10% bovine calf serum-Thermo Scientific Cat#
16030074). Cells were induced to differentiate using a standard MDI induction cocktail
of 0.5 mM 3-isobutyl-1-methylxanthine (MIX), 1 µM dexamethasone, and 1.7 µM
insulin in DMEM containing 10% FBS (Thermoscientific Cat# A31605). Cell cultures
were collected at stages of preadipocytes and mature adipocytes by adding IP buffer and
a mixture of protease and phosphatase inhibitors were added to collected protein samples
(same as above). After centrifugation at 13,000 x g for 10 min at 4C, the resulting
supernatants were used for immunoprecipitation. A BCA analysis (listed above) was
performed to quantify the amount of protein and 200 µg of protein was used. 25 µl of
bead slurry (Protein A/G Plus-Agarose Santa Cruz Biotechnology Cat# sc-2003) was
added to the sample and rocked for 1 hr in the cold room and were spun at 12,000 rpm for
1 min. 5 µg of the appropriate antibody was added to each sample and incubated on the
rocker in the cold room for one hour or overnight. After the incubation, samples were
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centrifuged for 1 to 3 mins at 13,000 rpm. Supernatant was carefully aspirated or
collected for western blot analysis. Beads were then washed 3 times by adding 1 ml of
cold IP buffer and centrifuge for 1-3 mins at 10,000 rpm. A sample of whole cell lysate
and an IP buffer with no cell lysate was used as a negative control to ensure that there
was no unspecific binding of the beads to protein samples.
2.3
2.3.1

Results

Reduced Expression of the Kinase Module Subunits in Specific Fat Tissue

Depots
Previous studies have shown that the kinase module is dissociated from the
Mediator complex and degraded upon nutrient signals in mouse liver.136 To determine
whether the kinase module subunits of the Mediator complex are also regulated by
nutrient availability in other tissues, the protein levels of different fat tissue depots
(iWAT, gWAT, rWAT, mWAT, and BAT) were compared between mice that were
fasted overnight and those that were fed for 4 hours following the overnight fast. As
observed in the previous study, the mouse liver extracts displayed reduced levels of the
kinase module subunits in the fed state. Similarly, there was also a reduction in MED13,
MED12, CDK8, and CCNC in tissues iWAT, rWAT, and gWAT (Figure 2-3A, 2-3B &
2-3C). Whereas there was no significant change in expression of the kinase subunits in
tissues mWAT and BAT (Figure 2-4A and 2-4B) suggesting that the transcriptional
control is different with nutrient availability in certain fat tissue depots.
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Figure 2-3: Decreased expression of kinase module subunits upon feeding following
fasting. 14-week-old female mice were subjected to the fasting and feeding protocol (n=3
per group). Western blot analysis of the Mediator kinase module subunits with fasting
and feeding of mouse adipose tissue depots. A) representative western blot of iWAT, B)
gWAT, and C) rWAT. 1 & 2 represent the samples collected from two different mice.

Figure 2-4: Consistent expression of kinase module subunits upon feeding following
fasting in mWAT and BAT. 14-week-old female mice were subjected to fasting and
feeding protocol (n=3 per group). Western blot analysis of the Mediator kinase module
subunits with fasting and feeding of mouse adipose tissue depots. A) representative
western blot of mWAT and B) BAT. 1 & 2 represent the samples collected from two
different mice.
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2.3.2

Differential Interaction of MED12 and CDK8 with Adipogenic Transcription

Factors in Pre- and Mature Adipocytes
To explore the interactions of MED12 and CDK8 with the regulators of
adipogenesis, protein-protein interactions were examined using immunoprecipitation
analysis. 3T3L1 preadipocytes and mature adipocytes were cultured, and protein was
collected. As shown MED12 interacts with PPARγ, C/EBPα, and STAT5A in both preand mature adipocytes (Figure 2-5). Interestingly, MED12 interacts with PPARγ1 than
PPARγ2 in both pre- and mature adipocytes suggesting that MED12 might play a role in
driving adipogenesis as it also interacts with C/EBPα, which is known to activate PPARγ
for initiation and progression of adipogenesis. MED12 also interacts with STAT5A,
known to promote adipogenesis, in both pre- and mature adipocytes. Whereas CDK8
interacts with C/EBPα in both pre- and mature adipocytes, there was no significant
interaction with PPARγ and STAT5A (Figure 2-6).
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Figure 2-5: Interaction of MED12 with transcription regulators in pre- and mature
adipocytes. 200ul of protein lysate collected from cultured 3T3L1 mouse pre- and mature
adipocytes were incubated with 5ul of MED12 antibody and the precipitated
immunocomplexes were subjected to western blot. Whole cell lysate and IP lysis buffer
were used as positive and negative control. IP elute shows presence of respective protein
present with the immunoprecipitation.

Figure 2-6: Interaction of CDK8 with transcription regulators in pre- and mature
adipocytes. 200ul of protein lysate collected from cultured 3T3L1 mouse pre- and mature
adipocytes were incubated with 5 ul of CDK8 antibody and the precipitated
immunocomplexes were subjected to western blot. Whole cell lysate and IP lysis buffer
were used as positive and negative control. IP elute shows presence of respective protein
present with the immunoprecipitation.
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2.4

Discussion

The Mediator complex is a multi-subunit protein complex that directly binds to
RNA Polymerase II and multiple DNA sequence-specific transcription factors. The
Mediator complex integrates and conveys gene-specific regulation of initiation and
elongation of transcription. Biochemical analyses of the Mediator complex have
identified at least two major complexes: the large or complete Mediator complex and the
small or core Mediator, which lacks the kinase module. Previous studies suggest that the
core Mediator primarily functions during initiation, whereas the large Mediator complex
participates in elongation of transcription. It has been assumed that the large and small
Mediator complexes control different subsets of regulated gene expression.68,137,138
Although recent studies have shown that the kinase subunit levels are regulated under
various nutritional states in the mouse liver, it still remains to be seen if this is true in
other tissues. A study by Youn et al. in mouse liver revealed a dynamic oscillation of
different forms of the Mediator complexes between fasting and feeding. Their data
indicate that the hepatic Mediator complex primarily exists in the form of the large
Mediator complex in the fasted state and following feeding, the kinase module undergoes
dissociation and degradation, resulting in the formation of the small Mediator complex.136
This study of mouse adipose tissue revealed a regulated expression of the kinase
subunits of the Mediator complex between fasting and feeding. Based on the western
blots, the data demonstrates that the expression of the kinase module subunits during
feeding was reduced compared to the expression in the fasted state in certain adipose
tissue depots (iWAT, gWAT, and rWAT). However, kinase module expression remains
same in mWAT and BAT. This suggests that following feeding, the kinase module
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undergoes dissociation and degradation, resulting in the formation of the small Mediator
complex. Although the regulation and mechanism of the dissociation and degradation of
the kinase module subunits remains unclear, this data suggests that the previous
identification of size oscillation of the Mediator complex in mouse livers might be
replicated in certain adipose tissues. Although we are yet to identify the specific
component regulating expression of the kinase module subunits, it is likely that the
feeding induced activation of mTORC1 might be necessary and sufficient for reduced
expression of the kinase module subunits in certain adipose tissues correlated with the
dissociation and degradation of the kinase module in mouse livers. mTORC1, is an
important target of numerous signaling pathways and serves as a critical sensor of
nutrient status. Previous research provide evidence that in vivo hepatic mTORC1
activation leads to activation of lipogenic gene expression.61,136 However, whether
mTORC1 activation is necessary for activation of gene expression during lipogenesis in
adipose tissue is yet to be determined.
Despite this caveat, immunoprecipitation analysis reveals that MED12 interacts
with adipogenic transcription factors, PPARγ and C/EBPα in both pre- and mature
murine adipocytes, suggesting a possible crucial role for MED12 in initiation and
maintenance of adipogenesis. Analysis of interaction between MED12 with PPARγ
indicates an interaction with PPARγ1 but not PPARγ2 in both pre- and mature
adipocytes. These data demonstrate that of the two isoforms of PPARγ, PPARγ1 appears
to have more affinity to bind to MED12 than PPARγ2 and vice versa. Interestingly,
MED12 is also found to interact with STAT5A in both pre and mature adipocytes.
STAT5A is known to promote adipogenesis in 3T3-L1 murine cells139 and so this
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interaction further supports the possibility of MED12 in promoting and maintaining
adipogenesis.
CDK8 controls mechanisms of transcription factor turnover, regulation of CTD
phosphorylation and regulation of activator or repressor functions that are associated with
both positive and negative effects on transcription70,97,140. Furthermore, CDK8 has
emerged as a key regulator of multiple transcription programs linked to differentiation
control. In agreement with these results, using 3T3-L1 murine pre and mature adipose
cells, immunoprecipitation analysis reveals that CDK8 interacts with C/EBPα. However,
there is little to no interaction of CDK8 with PPARγ and STAT5A in both pre and mature
adipocytes. Although it remains to be determined whether or not CDK8 interacting
proteins are phosphorylated, as CDK8 is primarily thought to be negatively regulating the
initiation of transcription.68 This study shows for the first time that the reduced
expression of the kinase subunit proteins of the Mediator complex in certain adipose
tissue depots under nutrient regulated conditions and that MED12 and CDK8, subunits of
same module have differential interaction with adipogenic regulators in vivo.

CHAPTER 3
EXPRESSION AND INTERACTION OF THE KINASE MODULE
SUBUNITS DURING ADIPOGENESIS OF hASCs
3.1

Introduction

Individuals with obesity are more likely to develop type 2 diabetes and
cardiovascular disease. The disproportionate increase of adipose tissue and its resulting
inflammation especially in the visceral regions, is linked to development of metabolic
disorders. Over the past two decades, researchers have embarked on understanding the
function of adipocytes and the transcriptional events regulating adipogenesis in vitro.
Adipogenesis is a differentiation process of forming adipocytes from preadipocytes or
precursor cells and is regulated by an elaborate network of transcription factors that
coordinate expression of many proteins responsible for progression and maintenance of
fat cell phenotype.141 Adipose-derived stem cells (ASCs) are a type of adult stem cells
known for their high plasticity and their ability to generate cell types of mesodermal and
non-mesodermal lineages including adipocytes, osteocytes, and chondrocytes. The ability
of stem cells to differentiate into different lineages is the basis for tissue regeneration and
repair.2,18,20 Disruption in the differentiation process often leads to impaired metabolic
processes and can result in disease.142,143 Understanding the complex regulatory
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mechanism of adipocyte differentiation can contribute to clinical treatment of human
diseases, including those caused by obesity and adipocyte dysfunction.
Several transcription factors have been implicated in this process, including the
C/EBP proteins, the nuclear receptor PPARγ, and the helix-loop-helix protein SREBP1c.
Several studies in murine adipogenic cell line models have shown that induction of
differentiation causes increased expression of C/EBPβ and C/EBPδ.121,141,144,145 Together
these proteins enhance the expression of C/EBPα and PPARγ. C/EBPα and PPARγ are
responsible for gene expression changes characteristic of mature adipocytes and are able
to induce each other’s expression to promote and maintain the adipogenic state.
Importantly, precursor cells were able to differentiate into fat cells in the absence of
C/EBPα but not in the absence of PPARγ demonstrating that PPARγ is an essential
regulator of adipogenesis.144 Moreover, SREBP1c has been found to promote
adipogenesis through PPARγ in addition to activating expression of key genes that
regulate fatty acid metabolism.145 Taken together, the adipocyte differentiation program
is regulated by transcription factors (Figure 3-1), along with their cofactors that regulate
the expression of genes involved in promoting and maintaining the adipocyte phenotype.
Among the transcription coactivators, a multi-subunit protein complex called the
Mediator complex has been linked to several of these transcription factors.
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Figure 3-1: Schematic figure of the regulation of adipogenesis. Adipogenesis is a
sequential cascade of transcription factors leading to lipid accumulation and the
acquisition of insulin sensitivity involving key regulators that help differentiate and
maintain adipose state.
The Mediator complex binds to various cell-type specific transcription factors and
relays the transcriptional signals to RNA polymerase. The mammalian Mediator is
composed of 30 subunits grouped into four modules. The most unique module with
reversible binding ability to core Mediator is the kinase module consisting of four
conserved subunits MED13, MED12, CDK8, and CCNC. Paralogs have been identified
for three of them i.e., MED13L, MED12L, and CDK19 with fewer known functions and
are mutually exclusive with MED13, MED12, and CDK8, respectively.44 The kinase
module was originally considered as a transcriptional repressor, but later found to both
activate and repress gene expression through kinase dependent and kinase independent
mechanisms.140 Many biochemical, molecular, and physiological studies using cell lines
or model organisms have shown diversified functional roles of the Mediator complex.
However, the physiological role of the Mediator complex especially the kinase module
remains to be explored. Among the four subunits of the kinase module, the CDK8-CCNC
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dimer has been studied for its role in lipogenic gene expression, where the dimer
negatively regulates de novo lipogenesis through reduction in SREBP1c protein by
phosphorylation.53,61 Furthermore, knockdown of CDK8 in mouse livers showed elevated
lipid levels in blood, supporting the CDK8 function in negative regulation of lipogenesis.
Recent studies have further shown reduced expression of CDK8 and CCNC in mouse
livers through mTORC1 nutrient signaling upon feeding or insulin resistant state or nonalcoholic fatty liver disease state.61 In addition to CDK8-CCNC studies, MED13 has also
been studied for its role in metabolic regulation. MED13 is found to inhibit the
expression of genes involved in glucose metabolism in skeletal muscles. Interestingly,
MED13 regulates genes involved in energy expenditure and metabolic rate where the
deletion of MED13 in cardiac cells resulted in elevated lipid levels independent of food
intake levels.56,146,147 To date, not much information is available on the functions of
MED12 individually or as a part of the kinase module in metabolic regulation processes.
This study investigates the gene and protein expression profiles of the kinase
module subunits during adipogenesis in vitro using cultured hASCs. The mRNA and
protein levels of the kinase module subunits were observed to fluctuate through
adipogenic differentiation. MED12-knockdown hASCs showed reduced adipogenesis as
well as reduced expression of PPARγ, indicating a role for this protein in directing stem
cell fate. Finally, we observed that MED12 interacts with PPARγ and C/EBPα at all
stages of adipogenesis, but it interacts with SREBP1c only in mature state of
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adipogenesis. Altogether, this study suggests a possible indispensable role for MED12 in
vitro in promoting and maintaining adipogenesis.
3.2
3.2.1

Materials and Methods

Cell culture and Differentiation
Human Adipose-derived Stem Cells (hASCs) were cultured on 10 cm tissue

culture treated polystyrene dishes in complete culture medium (CCM) containing αMEM
1x (Life Technologies, Cat# 12561049), 16.5% Fetal Bovine Serum (FBS, Atlanta
Biologicals, Cat# S11550), 1% L-glutamine 200 mM (100x) (Gibco Cat #25030-081),
and 1% Penicillin Streptomycin (Life Technologies Cat#15140122). Cells were incubated
at 37°C at 5% CO2 and media was changed every 48 hours to ensure the cells were
receiving proper nutrients. hASCS cultured till they reached 70-80% confluency and
adipogenesis was induced through the addition of AdipoQual medium (LaCell Cat#
LaADM-500). Media was changed every 72 hours until collected at different timepoints
(day 7, day14, and day 21).
3.2.2

siRNA Mediated Transfection
hASCs were cultured until they were 30-50% confluent and transfected with

negative control (Thermo Scientific Cat#4390843) and MED12-specific siRNA
(5nmol/ml) (Thermo Fisher Scientific Cat#s19364) using Lipofectamine RNAiMAX
reagent (Life Technologies Cat#13778075) following manufacturer’s protocol. Media
was changed 24 hours after transfection.
3.2.3

Oil red O Staining
Oil Red O stock solution was prepared using 0.5g of solid Oil Red O (VWR

Cat#11411-412) and 100ml of 100% isopropanol. Working solution was prepared from
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stock solution in a 3:2 ratio of stock solution with distilled water and filtered through a
0.22 µm syringe filter. Cells were fixed with a 10% formalin solution and incubated at
room temperature for 15 minutes. Oil Red O working solution was added to cells and
incubated for 20 minutes at room temperature. Cells were imaged in a Cytation 5 BioTek
Plate Reader.
3.2.4

RNA Extraction and cDNA Synthesis
Cultured cells were washed with PBS twice and RNA was collected using TRIzol

reagent (Ambion Cat#15596018). 1 ml of TRIzol reagent is added per 10 cm plate and
cells were scraped with a cell scrapper. RNA was extracted following the manufacturer’s
protocol. RNA was then quantified using a Take3 plate on a Cytation 5 BioTek Plate
Reader. qScript cDNA Supermix (VWR Cat#95048-100) was used to synthesize cDNA
using 1µg of RNA (used manufacturer’s protocol-Quanta Biosciences).
3.2.5

qRT-PCR
qRT-PCR was used to determine transcript levels of the kinase module subunits

and adipogenic markers expressed in hASCs at day 0, day 7, day 14, and day 21 after
differentiation. qRT-PCR was performed in technical triplicates using PowerUp SYBR
Green Master Mix (Thermo Fisher Scientific Cat#A25742), primers, and 1 µl of cDNA.
The reaction was run using a StepOnePlus Applied Biosystems machine standard
quantitation experiment. The data was plotted in excel using ΔΔ CT curve. The primer
sequences used are listed in Table 3-1.
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Table 3-1: List of primer sequences used for qRT-PCR

Gene

Forward Sequence (5’-3’)

Reverse Sequence (3’-5’)

gapdh

CCCCACTTGATTTTGGAGGGA

AGGGCTGCTTTTAACTCTGGT

206

med12

CGAAAAGGGACAGCAGAAAC

CCCATCCTCCCCACCTAAGA

87

med13

TGTCCTGCTCCTTCACCTTTT

GGCATAAGATAACTTGAAATGGGCT

150

ccnc

GCTGATTTGATCGAGGAGCG

ATCCATTGCAAATAGTGGGAGC

148

cdk8

GCCAAGAGGAAAGATGGGAAGG

GCCGACATAGAGATCCCAGTT

77

pparγ

GCTGTTATGGGTGAAACTCTG

ATAAGGTGGAGATGCAGGTTC

151

c/ebpα

TATAGGCTGGGCTTCCCCTT

AGCTTTCTGGTGTGACTCGG

94

tubulin1
-α

CCAGGGCTTCTTGGTTTTCC

CGCTCAATGTCGAGGTTTCT

167

srebp1c

CTCTTGAAGCCTTCCTGAG

GCACTGACTCTTCCTTGAT

138

3.2.6

Size
(bp)

Protein Extraction and Western Blot
Cultured cells were washed twice with ice cold PBS and harvested on ice using

400 uL of RIPA lysis buffer (Thermo Fisher Scientific Cat#89900)) supplemented with
Halt Protease and Phosphatase inhibitor Single-Use Cocktail (Thermo Fisher Scientific
Cat#78441). Whole cell lysates were then agitated for 30 min at 4 °C and then
centrifuged for 20 mins at 12,000 RPM at 4 °C. Protein samples were quantified using
BSA standard curve generated using Bradford assay. SDS-PAGE was performed using

51
standard protocol for Mini-PROTEAN TGX 4-15% (Bio-Rad Cat#456-1084)). Proteins
were transferred onto a PVDF membrane (Thermo Fisher Scientific Cat#88518) at 100V
for 1 hr. The transferred membrane was blocked in 5% non-fat dry milk in 1x TBS with
0.1% Tween-20. The blocked PVDF membranes were cut according to the size of target
protein and were probed overnight at 4 °C with respective antibody. Membranes were
washed 4 times with TBST, 5 mins each and probed with secondary antibody for 1 hr at
room temperature. Blots were developed using ECL reagents (BioRad Cat#1705060) and
images were taken using chemiluminescence Chemdoc machine (BioRad). The list of
antibodies used for western blot are listed in Table 3-2.
Table 3-2: List of antibodies used for western blot analysis

Antibody

Size (k Da)

Host
species

Company

Catalog No.

Dilution

MED12

250

Rabbit

Bethyl
Laboratories

A300-774A

1:1000

MED13

268

Rabbit

Bethyl
Laboratories

A301-278A

1:1000

CDK8

58

Rabbit

Bethyl
Laboratories

A302-501AM

1:1000

CCNC

28

Rabbit

Bethyl
Laboratories

A301-989A

1:1000

PPARγ

53, 57

Rabbit

ThermoFisher

PA3-821A

1:500

C/EBPα

30 & 42

Rabbit

ThermoFisher

PA1-337

1:1000

GAPDH

37

Rabbit

Abcam

Ab9485

1:1000
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3.2.7

Co-Immunoprecipitation Assay (Co-IP)
Protein for Co-IP assays was collected as described above but used IP lysis buffer

instead of RIPA buffer. The collected protein was agitated for 5 mins at 4°C and
centrifuged at 13,000 XG for 10 mins. The supernatant was collected and quantified
using Bradford assay. Co-IPs were performed using the Pierce Crosslink Magnetic IP/CoIP kit following the manufacturer’s protocol (Thermo Fisher Scientific Cat#88805). 5 µl
of polyclonal antibody was used per 200 µg of lysate. Collected elution and unbound
lysates were used for western blot analysis.
3.2.8

Statistical Analysis
Data were presented as the mean +/- standard deviation (SD). Graphs were

generated using Student’s t test with P<0.05 considered statistically significant.
3.3
3.3.1

Results

The Expression of Kinase Module Subunits of The Mediator Complex

Fluctuates During Adipogenesis of hASCs
To investigate the potential role of the Mediator kinase module subunits in
adipogenesis, the gene and protein expression profiles for each of the four subunits of the
kinase module were examined in hASCs induced to undergo adipogenesis. Cells were
visually examined at days 0, 7, 14, and 21 through phase-contrast imaging and Oil Red O
staining (Figure 3-2). Differentiation was confirmed by the increased presence of lipid
vesicles and changing expression profiles of adipogenic regulators C/EBPα, PPARγ, and
SREBP1c (Figure 3-3). The transcript levels of the kinase module subunits, i.e., MED12,
MED13, CDK8, and CCNC at different timepoints during adipogenesis had different
expression patterns with each timepoint (Normalized to gapdh) (Figure 3-4). The
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expression of med12 and ccnc followed the same trend where their expression increased
from day 0 to 14 into differentiation and dropped at day 21 upon reaching a mature state.
The expression of med13 increased consistently from day 0 to 21, whereas the expression
of cdk8 dropped at day 7 then increased over day 14 and 21. When examined together,
med12 appears to be transcribed at the highest levels with at least a fold change of 0.5 at
each time point. This suggests and supports a kinase-independent activity of MED12 in
transcription regulation in adult stem cells.57

Figure 3-2: Morphological characteristics of hASCs at different stages of adipogenic
differentiation. Pictures represent the morphology of differentiating cells in phasecontrast imaging (top row) and staining pattern of Oil Red O (bottom row) induced at day
0, 7, 14, and 21, respectively.
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Figure 3-3: Expression of adipogenic markers during adipogenesis of hASCs. A) mRNA
expression and B) Protein expression pattern of PPARγ, C/EBPα, and SREBP1c at
different timepoints during differentiation of hASCs. The mRNA expression level at day
0 was assigned as the control (Normalized to gapdh). Data represented as mean +/- SD
(*) P < 0.05 and (**) P < 0.01.

In contrast, the protein levels of MED12, CDK8, and CCNC demonstrated a
distinctive pattern throughout the progression of adipogenesis (normalized for the
GAPDH protein level), where the expression decreased during the middle stage and
increased again during the late stage of adipogenesis (Figure 3-5). However, MED13
remains consistent with transcript levels which steadily increased through day 21. The
reduction in protein levels of MED12, CDK8, and CCNC was observed and contrasted
with their respective mRNA levels suggesting post-translational modification.
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Figure 3-4: The relative mRNA expression of genes of the kinase module subunits
during adipogenesis of hASCs. Expression pattern of MED12, MED13, CDK8 and
CCNC at different timepoints during differentiation of hASCs. The mRNA expression
level at day 0 was assigned as the control. Data represented as mean +/- SD (*) P < 0.05.

Figure 3-5: The protein expression of subunits of the kinase module during adipogenesis
of hASCs. Expression pattern of MED12, MED13, CDK8 and CCNC over 21 days of
adipogenic differentiation of hASCs.
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3.3.2

MED12 Knockdown Leads to Decreased Adipogenesis in hASCs
As MED12 is a central part of the kinase module of the Mediator complex, we

tested whether the decreased expression of MED12 affects adipogenesis. To test this,
MED12 was knocked down in cultured hASCs just before inducing adipogenic
differentiation. Cells were collected at day 3, 7, and 14 of differentiation, and
adipogenesis was assessed based on morphology, Oil Red O staining, and transcription
factor profiles. Oil Red O staining indicated less lipid vesicle formation following the
decreased expression of MED12 (Figure 3-6A). MED12 knockdown was confirmed
using qRT-PCR (Figure 3-6B) and western blot (Figure 3-6C) showing less MED12 at
both transcript and protein levels, respectively.

Figure 3-6: MED12 knockdown during adipogenesis of hASCs. A) Morphological
characteristics with knockdown of MED12. Morphology of differentiating cells with
negative control (top row) and MED12 siRNA (bottom row) with phase-contrast (left
column) and Oil Red O staining (right column) during different stages of adipogenesis of
hASCs. Validation of MED12 knockdown via B) qRT-PCR analysis showing MED12
mRNA expression and C) Western blot showing MED12 protein expression during
adipogenesis of hASCs with MED12 knockdown. Also shows % of MED12 protein
remaining with ImageJ analysis. Data represented as (*) P < 0.05. Data Credit:
Onyekachi Idigo and Joseph Straub.
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To uncover additional molecular signatures related to adipogenesis, we examined
the expression of PPARγ, a master regulator of adipogenesis. We observed that both
mRNA and protein levels of PPARγ decreased with the diminished expression of MED12
(Figure 3-7A and 3-7B), suggesting that MED12 plays a role in adipogenic
differentiation.

Figure 3-7: Decreased PPARγ expression with MED12 knockdown A) qRT-PCR
analysis showing mRNA expression of PPARγ and B) Western blot analysis showing
protein expression of PPARγ during different stages of adipogenesis of hASCs with
MED12 knockdown. C) Image J analysis of protein levels. Data represented as (*) P <
0.05. mRNA Data credit: Onyekachi Idigo.

3.3.3

Loss of MED12 Disrupts Kinase Module
To test if the decreased expression of MED12 impacts the other kinase module

subunits, we examined both transcript and protein levels of MED13, CDK8, and CCNC.
Given the central location of MED12 between MED13 and CDK8/CCNC in the kinase
module, the decreased expression of CDK8/CCNC was expected with the knockdown of
MED12 as the CDK8/CCNC dimer is attached to MED12 through CCNC and this trio is
linked to core Mediator through MED13. Interestingly, qRT-PCR analysis of MED12
knockdown demonstrated significant change in med13, cdk8, and ccnc mRNA levels at
day3 and 7 of adipogenesis (Figure 3-8A). The protein expression of CDK8 remained
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unchanged, where as CCNC and MED13 demonstrated lower expression in MED12
knockdown cells compared to negative control cells throughout adipogenic
differentiation (Figure 3-8B). This data suggests a Mediator kinase independent role for
CDK8 even though its attachment to the Mediator core is disrupted through knockdown
of MED12.

Figure 3-8: Decreased kinase subunit expression with MED12 knockdown A) qRT-PCR
analysis showing mRNA expression and B) Western blot analysis showing protein
expression of MED13, CDK8, and CCNC with MED12 knockdown. Data represented as
(*) P < 0.05. mRNA Data Credit: Onyekachi Idigo

3.3.4

MED12 Interacts with Adipogenic Regulators During Adipogenesis of

hASCs
To further examine the interaction between MED12 and adipogenic regulators
including PPARγ, C/EBPα, and SREBP1c, co-immunoprecipitation (Co-IP) experiments
were performed during early, middle, and late stages of adipogenesis. As expected, the
MED12 pulldown assay revealed the presence of PPARγ and C/EBPα at all stages of
adipogenesis (Figure 3-9). Interestingly, MED12 interacts with SREBP1c only in the late
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stage i.e., in mature adipocytes (Figure 3-10). These results demonstrating the interaction
of MED12 with transcription regulators of adipogenesis support the notion that MED12
plays a possible role in initiating adipogenesis as well as maintaining the adipogenic
state. Other interaction partners included CDK8, CCNC, and MED13, where the
interaction between the kinase module subunits was evaluated. Interaction of MED12
with other subunits was found to be consistent throughout adipogenesis.

Figure 3-9: Interaction of MED12 with adipogenic regulators. Co-IP of MED12 during
different stages of adipogenesis, day 3, 7, and 14 (early, middle, and late). Cell lysates are
whole cell extracts of respective timepoints with negative control and MED12
knockdown. Co-IP represents the elution sample obtained after MED12 coimmunoprecipitation.
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Figure 3-10: Interaction of MED12 with adipogenic regulators and other kinase module
subunits at day 21 of adipogenesis. Co-IP of MED12 during day21 i.e., mature stage of
adipogenesis. WCE represents whole cell extract at day 21. Elute represents elution
sample obtained after MED12 co-immunoprecipitation. Unbound represents the
remaining sample content that the target protein doesn’t interact with.
Co-IP experiments following MED12 knockdown showed a reduction of PPARγ
presence in eluted samples, supporting the reduction in PPARγ and adipogenesis
following the decreased expression of MED12. Additionally, no significant reduction in
expression of C/EBPα was observed with MED12 knockdown even though the
interaction between these proteins is constantly present during all stages of adipogenesis.
This suggests that MED12 might be regulating adipogenesis through PPARγ. Overall,
these results provide a mechanistic insight for the maintenance of lineage-specific
transcription regulation by key adipogenic regulators.
3.4

Discussion

Differentiation is a well-orchestrated process that relies on the convergence of
environmental factors, cell-signaling, transcription factors, and gene expression
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regulation to produce a nearly irreversible alteration of a stem cell’s gene expression
profile, leading to an overall change in the stem cell’s cellular identity. Adipogenesis is
the process of a multipotent stem cell differentiating into a mature adipocyte capable of
accumulating and storing fatty acids within lipid vesicles. Mediator is found to play a
critical role in cell type-specific gene expression, and its role includes regulating activity
on the part of the kinase module. The kinase module plays a prominent role in gene
expression, and the results from this study point to possible MED12 involvement beyond
cell-fate determination and into maintenance of differentiated adipocytes. The data
demonstrating the link between MED12 and PPARγ via protein-protein interactions, has
illuminated the possibility that these two critical regulators act together during
adipogenesis. This possibility of working in coherence continues further into the later
stages of differentiation as shown by the interaction of MED12 with SREBP1c in mature
adipocytes.
Studies deciphering Mediator complex regulation are still in the early stages.
Altered phosphorylation has been observed as a mechanism for the regulation of
Mediator subunits.148 MED13/MED13L are shown to be regulated by ubiquitination,
which targets these subunits for degradation by SCF-Fbw7.34 It is likely that other posttranslational modifications regulate Mediator kinase subunits, and of particular interest
are those generated by metabolic pathways. Since Mediator kinase module subunits are
implicated as terminal signal transducers for many pathways, it is likely that the
expression of subunits is regulated in a context-specific manner. The post-translational
modifications resulting in different levels of kinase module subunits during adipogenesis
in vitro remains to be identified. We speculate that these contexts or metabolically

62
induced posttranslational modifications are intimately tied to the metabolic demand of
specific tissues and rapidly modulate the transcriptional gene network in response to
whole cell/tissue demands.
A number of studies have identified MED12 mutations in cancers.41,78,81 Since
mutations drive cancers and other developmental disorders, it is tempting to speculate
that MED12 mutations could give rise to metabolic disorders, as MED12 loss led to
diminished adipogenesis and PPARγ expression according to this study. Interestingly,
several of the adipogenic regulators interacting with MED12 during adipogenesis are also
frequently mutated in several metabolic disorders, including PPARγ, C/EBPα , and
SREBP1c.66,149 Future work will test whether these genetic events indeed induce
molecular disability by modulating transcription factor activity.

CHAPTER 4
CONCLUSIONS AND FUTURE WORK

4.1

Conclusions

Gene expression regulation in mammals is accomplished by coordinated action
of several transcription factors and their associated cofactors, which integrate signals
from different pathways. In particular, stem cells have numerous factors that can
influence stem cell fate including environmental stimulus, chromatin modifiers, signal
transduction molecules, and transcription machinery. Modification to even one of these
factors will change the genes expressed and the decision to continue self-renewal or
differentiate into a specific lineage. In recent years, interest has increased in studying
cofactors that bridge transcription factors and RNA polymerase to activate or repress the
transcription machinery in response to external signals. One of the recently identified
cofactors is the highly conserved Mediator complex, which has 30 subunits grouped into
four modules and is involved in various biological processes through interaction with
specific transcription factors. The four-subunit kinase module of the Mediator complex
consisting of MED12, MED13, CDK8, and CCNC can reversibly associate with the 26subunit Mediator core. The kinase module is able to alter the structure and function of
Mediator and has been established as an essential transcriptional cofactor of numerous
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developmental, biochemical, and metabolic processes. Mutations of any of these subunits
have been reported in mental diseases, metabolic disorders, and cancers.
Due to the prevalence of obesity, metabolic conditions related to obesity such as
type 2 diabetes, cardiovascular diseases, and cancer are becoming more common. The
common feature of these obesity-related disorders is dysregulation in lipid metabolism.
Adipogenesis, the developmental process of forming adipocytes from precursor cells, is
considered an important aspect of lipid metabolism and is tightly regulated by a
transcriptional cascade including transcription factors PPARγ, C/EBPα, and SREBP1c,
and cofactors including the Mediator complex. Recent studies have shown that Mediator
subunits play a crucial role as a cofactor for these transcription regulators, indicating a
possible role in adipogenesis/lipogenesis. Despite the growing research in this field, the
role of the kinase module subunits in adipogenesis has not yet been investigated. My
research focused specifically focused on investigating the role of kinase module subunits
during adipogenesis and their interaction with adipogenic transcription regulators.
Through molecular biology techniques, I have been able to demonstrate the fluctuations
in expression and interactions of the kinase module subunits in murine adipose tissue
depots during fasting and refeeding. This research helps bridge the knowledge gap that
exists in understanding the regulation of adipogenic differentiation of hASCs through
interaction with adipogenic transcription factors.
In Chapter 2 the refed mice demonstrated decreased expression of the kinase
module subunits compared to fasted mice in iWAT, gWAT, and rWAT. However, there
was no significant change in expression of the kinase module subunits in BAT and
mWAT. This could be an indication of activation of specific nutrient sensitive pathways
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upon refeeding following fasting that are responsible for the decrease in expression of
kinase module subunits. But the nutrient signaling, and the requirement of transcriptional
regulation is different for different tissue locations as evident by expression in BAT and
mWAT. This study also investigated the interaction of MED12 and CDK8 with
transcription regulators including PPARγ, C/EBPα, and STAT5A, where MED12 was
found to interact with all three in both murine pre and mature adipocytes. However,
CDK8 was observed to only interact with C/EBPα in both pre and mature adipocytes.
These interactions indicate that the subunits of the kinase module regulate different
metabolic processes through their differential interaction with transcription factors.
Chapter 3 focused on the expression of kinase module subunits during
adipogenesis of hASCs and the interaction of MED12 with key adipogenic regulators. By
culturing hASCs and differentiating into adipocytes, progression of adipogenesis was
evaluated through phase contrast imaging and Oil Red O staining. The mRNA and
protein expression of all the kinase module subunits during adipogenesis is inconsistent
throughout the differentiation, that is likely due to necessity of the subunits at each stage
of the differentiation process. Also, there was no correlation between the transcript and
protein levels, which could be because of varied post translational modifications. MED12
knockdown in hASCs resulted in a reduction of adipogenic differentiation in hASCs, as
indicated by reduced lipid vesicle formation and Oil red-O staining. Most importantly,
MED12 knockdown studies suggest that MED12 is indispensable for the progression of
adipogenesis. Co-immunoprecipitation analysis show that MED12 co-precipitates with
key adipogenic regulators, such as PPARγ, C/EBPα, or SREBP1c, which may be
recruiting MED12 to interact and cooperate with other transcriptional activators and co-
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activators to regulate adipogenesis. Supporting this notion, MED12 interacts with PPARγ
and C/EBPα at all stages of adipogenesis, an interaction that was reduced following the
knockdown of MED12. Thus, this study suggests that MED12 plays a critical role in
initiating adipogenesis in vitro. Interestingly, MED12 interacts with SREBP1c only
during late stage i.e., in mature adipocytes, supporting the idea that MED12 also might
play a role in maintenance of adipogenic state in vitro. Overall, this is the first study that
identified MED12 as a key regulator of adipogenesis in vitro and suggest the involvement
of MED12 beyond the point of cell fate determination and into the maintenance of
differentiated adipocytes.
4.2

Future Directions

The ultimate goal of this research is to gain a better understanding of adipogenesis
and its regulation by the Mediator kinase module subunits. From this work a critical role
for MED12 during in vitro differentiation was revealed that introduces an opportunity for
more in-depth mechanistic studies. By using different cell and molecular biology
techniques including cell culture, staining, qRT-PCR, western blot, Co-IP, and siRNA
mediated knockdown, I was able to demonstrate the importance of MED12 during
adipogenesis and its interaction with different adipogenic regulators.66,124 Having shown
that specific mice adipose tissue depots have reduced expression of the kinase module
subunits with refeeding following fasting, a possible future study as to why the same
adipose tissue at different locations have differential transcriptional control can be
explored. In addition, the possible reason behind the regulation of expression can be
explored in depth and if any of the kinase module subunits interact with lipogenic or
glucogenic genes that were affected by nutrient availability. Furthermore, the differential
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interaction of MED12 and CDK8 with transcription regulators can be further explored as
to find if they were enhancing or repressing gene expression through their interaction.
The difference in transcript and protein levels of the kinase module subunits
during adipogenesis of hASCs offers an additional way to study how post-translational
modifications regulate protein expression during adipogenesis. Since adipogenesis in
adult stem cells is highly characterized, this in vitro study using hASCs opens possible
routes of differentiation potential to be explored for clinical purposes. MED12 interaction
with master adipogenic regulators opens a whole area of research that can be explored in
terms of the Mediator subunits being the downstream target for a number of metabolic
pathways and how the mechanism of regulation influences cellular differentiation.

APPENDIX A
OPTIMIZATION OF SARS-COV2 DETECTION IN WASTEWATER
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A.1

Introduction

The newly emerged infectious Coronavirus disease 2019 (COVID 19) is caused
by a novel coronavirus called severe acute respiratory syndrome coronavirus 2 (SARSCoV-2). This epidemic disease, which started in December 2019, has spread worldwide
and turned into a pandemic causing global health emergencies and economic crises.150 To
date, there have been more than 166 million confirmed infections and more than 3.4
million deaths reported globally.151 Many studies have reported that many of the sickest
patients have been obese individuals who are 113% more likely to land in hospital and
48% more likely to die when compared to individuals of healthy weights.152,153 A number
of physiological factors drives the biology of obesity including impaired immunity,
chronic inflammation, and blood that’s prone to clot, all of which can worsen the
symptoms of COVID-19.
SARS-CoV2 is a type of human beta-coronavirus containing single stranded RNA
associated with a nucleoprotein within a capsid. Among all known RNA viruses,
coronaviruses possess the largest genomes with several conserved genes including spike
(S), envelope (E), membrane (M), and nucleocapsid (N), encoding for structural proteins
which are responsible for host infection (Figure A-1).150,154,155 The N protein is
responsible for packaging the viral genome into a helical ribo-nucleocapsid and is
relatively abundant during virus replication. Because of this targeting, the N gene (N1
and N2) of COVID-19 yielded diagnostic sensitivity and specificity for detecting
infections. Many studies showed that the N-gene based qRT-PCR assay was more
sensitive than any other genes for detection of COVID-19 soon after emergence of the
disease when limited genetic information was available.155–158 While the timely diagnosis

70
of the progressing infection is essential to prevent transmission, rapid assays and early
testing can have a risk of false-negative results. Keeping track of the full extent of the
ongoing pandemic is a constant challenge, as there is insufficient testing, delayed results,
and the absence of data from those who are asymptomatic. Researchers around the world
began to monitor sewage for traces of pathogen which provides an effective surveillance
of an entire community regardless of positivity rate.

Figure A-1: Graphical representation of SARS-CoV-2 structure. This picture shows the
spike protein, nucleocapsid protein and the viral RNA present in the virus. Image credit:
Kristin Jackson, VISTA.

Wastewater testing is an effective and widely known application which began in
the 1990s with efforts to eradicate poliovirus, and where it was shown to prevent
outbreaks.159 COVID-19, which is spread through respiratory droplets, is detected in
patient stool samples even before the onset of symptoms. Wastewater surveillance is
expected to lead diagnostic tests by a week given that shedding may occur soon after
infection, whereas an infected person may develop symptoms after 5-7 days of
infection.160,161 This study developed a method of tracking infection rates in the City of
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Ruston, LA. The samples were collected from the wastewater treatment plant in the city
of Ruston and processed to collect viral RNA. qRT-PCR analysis was performed for
genes N1 and N2 to assess the amount of SARS-CoV2 genome present in the wastewater.
The results demonstrate that a higher viral load is followed by rise in positive cases. It is
also evident that the infection rates were higher following events with large gatherings or
after breaks in the University’s schedule where students travel to see friends and family
before returning to campus. These data suggest that wastewater testing may be a
preliminary indicator of community transmission.
A.2
A.2.1

Materials and Methods

Sample Collection and Handling
Treated wastewater samples were obtained from the City of Ruston wastewater

twice a week. Samples were stored at 4oC or processed immediately after receiving.
Samples were centrifuged at 5000 RPM for 30 minutes to pellet the debris. Clear
supernatant was collected into another 50 ml tube and 0.9g NaCl and 4g PEG 8000 were
added per 40 ml by gentle rocking. Once completely dissolved, the samples were left at
least 1 hr or overnight at 4oC and centrifuged at 12,000G for 2 hours at 4oC. The
supernatant was poured out carefully and RNA was collected.
A.2.2

RNA extraction and cDNA synthesis
RNA was collected using TRIzol reagent (Ambion Cat#15596018) 1 ml per tube.

RNA was extracted using manufacturer’s protocol. Resulting RNA concentrations were
quantified by a plate reader with a Take3 plate (BioTek). cDNA was synthesized
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immediately after quantifying RNA using High-Capacity cDNA Reverse Transcription
Kit (Applied Biosystems Cat#4374966).
A.2.3

qRT-PCR
Determination of the number of viral genome copies per ml of wastewater was

analyzed by qRT-PCR. Primers and probes used included the N1 and N2 primers and
probe mix (2019-nCoV EUA, Integrated DNA Technologies Cat#10006770). Each 10 µl
of qRT-PCR reaction included 1x mastermix (Taqpath Applied Biosystems
Cat#A15297), 0.75 µl primer probe mix, 1µg of RNA sample, and PCR grade nuclease
free water. Each qRT-PCR run included a six-fold serial dilution of positive control
consisting of 2019-nCoV_N_Positive control (Integrated DNA Technologies
Cat#10006770) for genes N1 and N2 and was run in triplicates. The qRT-PCR was run in
a thermocycler (Applied Biosystems) with the conditions given by Centers for Disease
Control (CDC). Virus concentrations were determined by comparing Ct values of
samples against the standard curve from dilutions of the positive control. Dilution factor,
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volume of RNA used, and the total volume of sample in each well resulted in the
calculated genome units/ml of wastewater.
A.2.4

Statistical methods
The viral genome concentration per ml were represented with graphs over time

periods and the correlated data with positive cases were represented through Pearson’s
correlation using SPSS software.
A.3
A.3.1

Results

Optimization of Methodology for Quantitative Detection SARS-CoV-2 in
Wastewater
Multiple testing methods and laboratory workflows were used to quantify SARS-

CoV-2 in wastewater across the United States.161,162 All testing methods use sample
processing steps, use of laboratory controls, and implementation of biosafety measures to
ensure that the resulting data can be used for public health interpretation. Sample
processing is the most important part of wastewater testing as it involves the key steps
including sample preparation, sample concentration, RNA collection, extraction, and
quantification. Methods selected for each step were tailored for use with wastewater
depending on the appropriate laboratory conditions. It was initially challenging to
produce reliable outcomes as testing was relatively new to our laboratory and at least
initially, that time there was no standard operating procedure for SARS-CoV-2
wastewater detection.
Considerations for proper handling of samples include proper storage and transfer
of samples, sample concentration, RNA extraction, purification, and quantification, and
minimizing RNA degradation. Proper storage and preparing the samples ensures that
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SARS-CoV-2 RNA wastewater measurements are accurate. Concentration method
selection also depends on the processing time and availability of laboratory personnel.
RNA extraction and purification are an essential and crucial step in isolating SARS-CoV2 RNA from wastewater. Selecting an extraction protocol designed to produce highly
purified nucleic acid extracts was a challenging task. Upon using phenol/glycogen
standard method and an extraction kit designed specifically to purify viral RNA, we
chose standard method as optimal RNA extraction method for our laboratory setting.
Although using the extraction kit resulted in high purity of viral RNA, it had low
yield/concentration due to volume restriction through column (Table A-1). The biggest
challenge faced was avoiding degradation of RNA, when the sample was being handled
or processed, with of no way of knowing whether degradation occurred because of
sample mishandling or from lower concentrations of viral RNA in wastewater.
Overcoming these challenges and establishing a routine protocol to follow allowed us to
produce complementary COVID-19 surveillance indicator data.
Table A-1: An overview of difference between using different RNA extraction methods
for wastewater analysis.
Method/Kit used
RNA
Purity
Steps/Time
Conc
260/280
ng/ul
TRIzol/Chloroform/Glycogen ~180
~1.8-2.0
5/60mins
Viral RNA Extraction kitQiagen

A.3.2

~92

2.0

9/90mins

SARS-CoV2 RNA detection frequency and correlation with COVID-19
cases in Lincoln Parish
During the five-month study from August 2020 to January 2021, SARS-CoV-2

RNA was detected in wastewater from wastewater treatment facility in the City of Ruston
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(Figure A-2). In an effort to determine the relationship, if any, between SARS-CoV-2
viral concentrations in wastewater and COVID-19 disease burden, the new COVID-19
case counts reported to the City’s department of health were summed by week and case
rates were then plotted against the weekly SARS-CoV-2 genome concentration/ml in
wastewater.

Figure A-2: Average of SARS-CoV-2 viral genome units/ml of wastewater collected
from the city of Ruston versus the sampling period. SARS-CoV-2 viral genome units per
ml is calculated and plotted against the sampling period for N1 gene.
Abundance of SARS-CoV-2 RNA in wastewater from the city of Ruston
correlated with higher COVID-19 caseloads (Figure A-3). Time periods with higher
COVID-19 caseloads tended to have higher SARS-CoV-2 in wastewater a week prior to
the rise in number of positive cases. Specifically, the reporting period of early December
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had over 60 confirmed cases per day and correlated with higher viral concentration as
students returned for Winter quarter after Thanksgiving break.

Figure A-3: Correlation between SARS-CoV-2 genome concentration/ml of wastewater
and weekly average of positive COVID-19 cases. Red dots indicate any major events at
the University (LATECH) such as start date of fall classes, Halloween, football games,
quarter breaks etc.
Distinct trends in viral RNA abundance versus case counts were observed
throughout the testing period. First, SARS-CoV-2 wastewater loads in August and
September were lower compared to actual cases reported. Second, the spike in
wastewater viral loads during last week of October (Halloween) is followed by increase
in weekly COVID-19 cases from less than 10 to more than 25 per day. These results
suggest that the increase in case counts may occur concurrently with or even precede the
increase in SARS-CoV-2 RNA in wastewater. This variation in RNA in wastewater
versus case counts has been suggested by many other studies. Further, this long-term
shedding of the SARS-CoV-2 after negative test result may account for the detection of
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RNA in wastewater after the decline in cases. However, additional research would be
needed to confirm these observations during outbreaks.
A.4

Discussion

The newly emerged SARS-CoV-2 coronavirus causing COVID-19 developed into
a pandemic and is still threatening many countries with its rising infections. With an
unusually high number of cases and a limited number of testing facilities available,
researchers sought wastewater testing as a reliable tool for monitoring the need to
activate further clinical testing or other interventions in a particular area. This may be
especially useful in university areas where there is varied influx and outflux of students
that make up most of the community. However, there are several concerns with using this
analysis with false negative/positive signals from a few infected signals among
potentially large number of individual populations. Therefore, caution must be used in
designing samples for smaller systems to avoid providing false results that are applicable
in a critical public health setting.
In Ruston, LA, weekly sampling of wastewater provided community level
surveillance and identification of emerging outbreaks to help maximize the use of
targeted clinical testing. This research allowed us to identify certain time periods where
the rise in viral genome concentration is followed or correlated with the number of
positive cases. The city also plans to sample target smaller areas like specific buildings in
the University which increases the specificity of disease prevalence status. Further, this
information could support responsible vaccination and reopening local events when
appropriate and provide early warnings of breakouts.

BIBLIOGRAPHY

1.

2.
3.
4.

5.
6.
7.
8.
9.

10.
11.
12.
13.
14.
15.
16.
17.

Hayes, M., Curley, G., Ansari, B. & Laffey, J. G. Clinical review: Stem cell
therapies for acute lung injury/acute respiratory distress syndrome - hope or hype?
Crit. Care 16, 205 (2012).
Si, Z. et al. Adipose-derived stem cells: Sources, potency, and implications for
regenerative therapies. Biomedicine and Pharmacotherapy 114, 108765 (2019).
Straub, J., Venigalla, S. & Newman, J. J. Mediator’s Kinase Module: A Modular
Regulator of Cell Fate. Stem Cells Dev. 29, 1535–1551 (2020).
Schoettl, T., Fischer, I. P. & Ussar, S. Heterogeneity of adipose tissue in
development and metabolic function. Journal of Experimental Biology 121,
(2018).
Clark, A. D., Oldenbroek, M. & Boyer, T. G. Mediator kinase module and human
tumorigenesis. Crit. Rev. Biochem. Mol. Biol. 50, 393–426 (2015).
Cooper, G. M. Regulation of Transcription in Eukaryotes. (2000).
Lelli, K. M., Slattery, M. & Mann, R. S. Disentangling the many layers of
eukaryotic transcriptional regulation. Annual Review of Genetics 46, 43–68 (2012).
Holstege, F. C. P. et al. Dissecting the regulatory circuitry of a eukaryotic genome.
Cell 95, 717–728 (1998).
Kim, T. M. & Park, P. J. Advances in analysis of transcriptional regulatory
networks. Wiley Interdisciplinary Reviews: Systems Biology and Medicine 3, 21–
35 (2011).
Di Croce, L. & Helin, K. Transcriptional regulation by Polycomb group proteins.
Nature Structural and Molecular Biology 20, 1147–1155 (2013).
Rodda, D. J. et al. Transcriptional regulation of Nanog by OCT4 and SOX2. J.
Biol. Chem. 280, 24731–24737 (2005).
Shenghui, H., Nakada, D. & Morrison, S. J. Mechanisms of Stem Cell SelfRenewal. Annu. Rev. Cell Dev. Biol. 25, 377–406 (2009).
De Los Angeles, A. et al. Hallmarks of pluripotency. Nature 525, 469–478 (2015).
Felfly, H. & Haddad, G. G. Hematopoietic stem cells: potential new applications
for translational medicine. J. Stem Cells 9, 163–97 (2014).
Thomson, J. A. et al. Embryonic stem cell lines derived from human blastocysts.
Science 282, 1145–7 (1998).
Mahla, R. S. & Singh, R. Stem Cells Applications in Regenerative Medicine and
Disease Therapeutics. Int. J. Cell Biol. 2016, 1–24 (2016).
Ullah, I., Subbarao, R. B. & Rho, G. J. Human mesenchymal stem cells - current
78

79

18.
19.

20.
21.
22.

23.
24.
25.
26.

27.
28.
29.
30.
31.
32.
33.
34.

35.
36.
37.

trends and future prospective. Biosci. Rep. 35, (2015).
Gimble, J. M., Katz, A. J. & Bunnell, B. A. Adipose-derived stem cells for
regenerative medicine. Circ. Res. 100, 1249–1260 (2007).
Ge, X. et al. Isolation and Culture of Human Adipose-derived Stem Cells from
Subcutaneous and Visceral White Adipose Tissue Compartments. BIOPROTOCOL 6, (2016).
Tsuji, W., Rubin, J. P. & Marra, K. G. Adipose-derived stem cells: Implications in
tissue regeneration. World J. Stem Cells 6, 312–21 (2014).
Morrison, S. J. & Kimble, J. Asymmetric and symmetric stem-cell divisions in
development and cancer. Nature 441, 1068–1074 (2006).
Fong, H., Hohenstein, K. A. & Donovan, P. J. Regulation of Self-Renewal and
Pluripotency by Sox2 in Human Embryonic Stem Cells. Stem Cells 26, 1931–1938
(2008).
Kornberg, R. D. Mediator and the mechanism of transcriptional activation. Trends
in Biochemical Sciences 30, 235–239 (2005).
Allen, B. L. & Taatjes, D. J. The Mediator complex: A central integrator of
transcription. Nature Reviews Molecular Cell Biology 16, 155–166 (2015).
Tsai, K. L. et al. Subunit architecture and functional modular rearrangements of
the transcriptional mediator complex. Cell 157, 1430–1444 (2014).
Boube, M., Joulia, L., Cribbs, D. L. & Bourbon, H.-M. Evidence for a mediator of
RNA polymerase II transcriptional regulation conserved from yeast to man. Cell
110, 143–51 (2002).
Conaway, R. C. & Conaway, J. W. Function and regulation of the Mediator
complex. Current Opinion in Genetics and Development 21, 225–230 (2011).
Conaway, R. C. & Conaway, J. W. Origins and activity of the Mediator complex.
Semin. Cell Dev. Biol. 22, 729–734 (2011).
Whyte, W. A. et al. Master transcription factors and mediator establish superenhancers at key cell identity genes. Cell 153, 307–319 (2013).
Yin, J. & Wang, G. The Mediator complex: a master coordinator of transcription
and cell lineage development. Development 141, 977–87 (2014).
Imasaki, T. et al. Architecture of the Mediator head module. Nature 475, 240–3
(2011).
Cai, G. et al. Mediator Head module structure and functional interactions. Nat.
Struct. Mol. Biol. 17, 273–279 (2010).
Jeronimo, C. et al. Tail and Kinase Modules Differently Regulate Core Mediator
Recruitment and Function In Vivo. Mol. Cell 64, 455–466 (2016).
Davis, M. A. et al. The SCF-Fbw7 ubiquitin ligase degrades MED13 and
MED13L and regulates CDK8 module association with Mediator. Genes Dev. 27,
151–6 (2013).
Mo, X., Kowenz-Leutz, E., Xu, H. & Leutz, A. Ras induces mediator complex
exchange on C/EBP beta. Mol. Cell 13, 241–250 (2004).
Pavri, R. et al. PARP-1 determines specificity in a retinoid signaling pathway via
direct modulation of mediator. Mol. Cell 18, 83–96 (2005).
Tsai, K.-L. et al. A conserved Mediator-CDK8 kinase module association
regulates Mediator-RNA polymerase II interaction. Nat. Struct. Mol. Biol. 20,
611–9 (2013).

80
38.
39.

40.

41.
42.
43.
44.

45.

46.

47.
48.
49.
50.

51.

52.
53.

54.

55.

56.

Wang, X. et al. Structural flexibility and functional interaction of mediator Cdk8
module. Protein Cell 4, 911–920 (2013).
Knuesel, M. T., Meyer, K. D., Donner, A. J., Espinosa, J. M. & Taatjes, D. J. The
Human CDK8 Subcomplex Is a Histone Kinase That Requires Med12 for Activity
and Can Function Independently of Mediator. Mol. Cell. Biol. 29, 650–661 (2009).
Schneider, E. V., Böttcher, J., Huber, R., Maskos, K. & Neumann, L. Structurekinetic relationship study of CDK8/CycC specific compounds. Proc. Natl. Acad.
Sci. U. S. A. 110, 8081–8086 (2013).
Turunen, M. et al. Uterine Leiomyoma-Linked MED12 Mutations Disrupt
Mediator-Associated CDK Activity. Cell Rep. 7, 654–660 (2014).
Manning, G., Whyte, D. B., Martinez, R., Hunter, T. & Sudarsanam, S. The
protein kinase complement of the human genome. Science 298, 1912–1934 (2002).
Sato, S. et al. A set of consensus mammalian mediator subunits identified by
multidimensional protein identification technology. Mol. Cell 14, 685–691 (2004).
L. Daniels, D. Mutual Exclusivity of MED12/MED12L, MED13/13L, and
CDK8/19 Paralogs Revealed within the CDK-Mediator Kinase Module. J.
Proteomics Bioinform. 01, (2013).
Tsutsui, T. et al. Human mediator kinase subunit CDK11 plays a negative role in
viral activator VP16-dependent transcriptional regulation. Genes Cells 13, 817–
826 (2008).
Tsutsui, T. et al. Mediator complex recruits epigenetic regulators via its two
cyclin-dependent kinase subunits to repress transcription of immune response
genes. J. Biol. Chem. 288, 20955–20965 (2013).
MED12L. The Human Protein Atlas
Thul, P. J. et al. A subcellular map of the human proteome. Science 356, (2017).
Vogl, M. R. et al. Sox10 Cooperates with the Mediator Subunit 12 during
Terminal Differentiation of Myelinating Glia. J. Neurosci. 33, 6679–6690 (2013).
Muncke, N. et al. Missense mutations and gene interruption in PROSIT240, a
novel TRAP240-like gene, in patients with congenital heart defect (transposition
of the great arteries). Circulation 108, 2843–2850 (2003).
Cevher, M. A. et al. Reconstitution of active human core Mediator complex
reveals a critical role of the MED14 subunit. Nat. Struct. Mol. Biol. 21, 1028–
1034 (2014).
Adegbola, A. et al. Redefining the MED13L syndrome. Eur. J. Hum. Genet. 23,
1308–1317 (2015).
Napoli, C., Schiano, C. & Soricelli, A. Increasing evidence of pathogenic role of
the Mediator (MED) complex in the development of cardiovascular diseases.
Biochimie 165, 1–8 (2019).
Miao, Y.-L. et al. Mediator complex component MED13 regulates zygotic genome
activation and is required for postimplantation development in the mouse †, ‡.
Biol. Reprod. 98, 449–464 (2018).
Utami, K. H. et al. Impaired development of neural-crest cell-derived organs and
intellectual disability caused by MED13L haploinsufficiency. Hum. Mutat. 35,
1311–1320 (2014).
Asadollahi, R. et al. Genotype-phenotype evaluation of MED13L defects in the
light of a novel truncating and a recurrent missense mutation. Eur. J. Med. Genet.

81

57.

58.

59.
60.

61.
62.

63.
64.
65.

66.

67.
68.
69.
70.

71.
72.
73.
74.
75.

60, 451–464 (2017).
Aranda-Orgilles, B. et al. MED12 Regulates HSC-Specific Enhancers
Independently of Mediator Kinase Activity to Control Hematopoiesis. Cell Stem
Cell 19, 784–799 (2016).
Rocha, P. P., Scholze, M., Bleiss, W. & Schrewe, H. Med12 is essential for early
mouse development and for canonical Wnt and Wnt/PCP signaling. Development
137, 2723–2731 (2010).
Westerling, T., Kuuluvainen, E. & Mäkelä, T. P. Cdk8 Is Essential for
Preimplantation Mouse Development. Mol. Cell. Biol. 27, 6177–6182 (2007).
Kelleher, R. J., Flanagan, P. M. & Kornberg, R. D. A novel mediator between
activator proteins and the RNA polymerase II transcription apparatus. Cell 61,
1209–1215 (1990).
Feng, D. et al. mTORC1 down-regulates cyclin-dependent kinase 8 (CDK8) and
cyclin C (CycC). PLoS One 10, (2015).
Zhang, S., O’Regan, R. & Xu, W. The emerging role of mediator complex subunit
12 in tumorigenesis and response to chemotherapeutics. Cancer 126, 939–948
(2020).
Mäkinen, N. et al. MED12, the mediator complex subunit 12 gene, is mutated at
high frequency in uterine leiomyomas. Science (80-. ). 334, 252–255 (2011).
Li, N. et al. Cyclin C is a haploinsufficient tumour suppressor. Nat. Cell Biol. 16,
1080–1091 (2014).
Ohata, N. et al. Highly frequent allelic loss of chromosome 6q16-23 in
osteosarcoma: Involvement of cyclin C in osteosarcoma. Int. J. Mol. Med. 18,
1153–1158 (2006).
Song, Z. et al. Cyclin C regulates adipogenesis by stimulating transcriptional
activity of CCAAT/enhancer-binding protein α. J. Biol. Chem. 292, 8918–8932
(2017).
Miyata, Y. et al. Cyclin C regulates human hematopoietic stem/progenitor sell
quiescence. Stem Cells 28, 308–317 (2010).
Akoulitchev, S., Chuikov, S. & Reinberg, D. TFIIH is negatively regulated by
cdk8-containing mediator complexes. Nature 407, 102–106 (2000).
Zhao, J., Ramos, R. & Demma, M. CDK8 regulates E2F1 transcriptional activity
through S375 phosphorylation. Oncogene 32, 3520–3530 (2013).
Elmlund, H. et al. The cyclin-dependent kinase 8 module sterically blocks
Mediator interactions with RNA polymerase II. Proc. Natl. Acad. Sci. U. S. A. 103,
15788–15793 (2006).
Adler, A. S. et al. CDK8 maintains tumor dedifferentiation and embryonic stem
cell pluripotency. Cancer Res. 72, 2129–2139 (2012).
Firestein, R. et al. CDK8 is a colorectal cancer oncogene that regulates β-catenin
activity. Nature 455, 547–551 (2008).
Kapoor, A. et al. The histone variant macroH2A suppresses melanoma progression
through regulation of CDK8. Nature 468, 1105–1111 (2010).
Gu, W. et al. Tumor-suppressive effects of CDK8 in endometrial cancer cells. Cell
Cycle 12, 987–999 (2013).
Chung, H. lok et al. De Novo Variants in CDK19 Are Associated with a Syndrome
Involving Intellectual Disability and Epileptic Encephalopathy. Am. J. Hum.

82

76.
77.
78.
79.
80.

81.
82.
83.
84.
85.
86.

87.
88.
89.
90.
91.

92.

93.

94.

95.

Genet. 106, 717–725 (2020).
Becker, F. et al. Increased mediator complex subunit CDK19 expression associates
with aggressive prostate cancer. Int. J. Cancer 146, 577–588 (2020).
Clark, A. D., Oldenbroek, M. & Boyer, T. G. Mediator kinase module and human
tumorigenesis. Crit. Rev. Biochem. Mol. Biol. 50, 393–426 (2015).
Kämpjärvi, K. et al. Mutations in exon 1 highlight the role of MED12 in uterine
leiomyomas. Hum. Mutat. 35, 1136–1141 (2014).
Makinen, N. et al. MED12 exon 2 mutations in histopathological uterine
leiomyoma variants. Eur J Hum Genet 21, 1300–1303 (2013).
Je, E. M., Kim, M. R., Min, K. O., Yoo, N. J. & Lee, S. H. Mutational analysis of
MED12 exon 2 in uterine leiomyoma and other common tumors. Int J Cancer 131,
E1044–E1047 (2012).
Wu, B. et al. MED12 mutations and NOTCH signalling in chronic lymphocytic
leukaemia. Br. J. Haematol. 179, (2017).
Bullerdiek, J. & Rommel, B. Factors targeting MED12 to drive tumorigenesis?
F1000Research 7, 359 (2018).
Barbieri, C. E. et al. Exome sequencing identifies recurrent SPOP, FOXA1 and
MED12 mutations in prostate cancer. Nat. Genet. 44, 685–689 (2012).
Shaikhibrahim, Z. et al. MED12 overexpression is a frequent event in castrationresistant prostate cancer. Endocr. Relat. Cancer 21, 663–675 (2014).
Tutter, A. V. et al. Role for Med12 in regulation of Nanog and Nanog target genes.
J. Biol. Chem. 284, 3709–3718 (2009).
Papadopoulou, T., Kaymak, A., Sayols, S. & Richly, H. Dual role of Med12 in
PRC1-dependent gene repression and ncRNA-mediated transcriptional activation.
Cell Cycle 15, 1479–93 (2016).
Rump, P. et al. A novel mutation in MED12 causes FG syndrome (Opitz-Kaveggia
syndrome). Clin. Genet. 79, 183–188 (2011).
Risheg, H. et al. A recurrent mutation in MED12 leading to R961W causes OpitzKaveggia syndrome. Nat. Genet. 39, 451–453 (2007).
Schwartz, C. E. et al. The original Lujan syndrome family has a novel missense
mutation (p.N1007S) in the MED12 gene. J. Med. Genet. 44, 472–477 (2007).
Vulto-Van Silfhout, A. T. et al. Mutations in MED12 cause X-linked ohdo
syndrome. Am. J. Hum. Genet. 92, 401–406 (2013).
Onken, M. D. et al. A surprising cross-species conservation in the genomic
landscape of mouse and human oral cancer identifies a transcriptional signature
predicting metastatic disease. Clin. Cancer Res. 20, 2873–2884 (2014).
Monni, O. et al. Comprehensive copy number and gene expression profiling of the
17q23 amplicon in human breast cancer. Proc. Natl. Acad. Sci. U. S. A. 98, 5711–
5716 (2001).
Miao, Y.-L. et al. Mediator complex component MED13 regulates zygotic genome
activation and isrequired for postimplantation development in the mouse. Biol.
Reprod. 98, 449 (2018).
El Khattabi, L. et al. A Pliable Mediator Acts as a Functional Rather Than an
Architectural Bridge between Promoters and Enhancers. Cell 178, 1145-1158.e20
(2019).
Asadollahi, R. et al. Dosage changes of MED13L further delineate its role in

83

96.
97.
98.
99.

100.

101.
102.
103.
104.
105.
106.
107.
108.
109.
110.
111.
112.

113.
114.

115.

116.

congenital heart defects and intellectual disability. Eur. J. Hum. Genet. 21, 1100–
1104 (2013).
Akoulitchev, S., Chuikov, S. & Reinberg, D. TFIIH is negatively regulated by
cdk8-containing mediator complexes. Nature 407, 102–106 (2000).
Galbraith, M. D., Donner, A. J. & Espinosa, J. M. CDK8: a positive regulator of
transcription. Transcription 1, 4–12 (2010).
Lai, F. et al. chromatin architecture and transcription. Nature 494, 497–501
(2013).
Donner, A. J., Ebmeier, C. C., Taatjes, D. J. & Espinosa, J. M. CDK8 is a positive
regulator of transcriptional elongation within the serum response network. Nat.
Struct. Mol. Biol. 17, 194–201 (2010).
Youn, D. Y., Xiaoli, A. M., Kwon, H., Yang, F. & Pessin, J. E. The subunit
assembly state of the Mediator complex is nutrient-regulated and is dysregulated
in a genetic model of insulin resistance and obesity. J. Biol. Chem. 294, 9076–
9083 (2019).
Firestein, R. et al. CDK8 is a colorectal cancer oncogene that regulates betacatenin activity. Nature 455, 547–551 (2008).
Gao, S. et al. Ubiquitin ligase Nedd4L targets activated Smad2/3 to limit TGF-beta
signaling. Mol. Cell 36, 457–468 (2009).
Chen, M. et al. CDK8/19 Mediator kinases potentiate induction of transcription by
NFκB. Proc. Natl. Acad. Sci. U. S. A. 114, 10208–10213 (2017).
Klatt, F. et al. A precisely positioned MED12 activation helix stimulates CDK8
kinase activity. Proc. Natl. Acad. Sci. U. S. A. 117, 2894–2905 (2020).
Wang, X. Stem cells in tissues, organoids, and cancers. Cell. Mol. Life Sci. 76,
4043–4070 (2019).
Bird, A. Perceptions of epigenetics. Nature 447, 396–398 (2007).
Zhang, H. & Wang, Z. Z. Mechanisms that mediate stem cell self-renewal and
differentiation. J. Cell. Biochem. 103, 709–718 (2008).
Cho, I. J. et al. Mechanisms, Hallmarks, and Implications of Stem Cell
Quiescence. Stem cell reports 12, 1190–1200 (2019).
Obesity and overweight. Available at: https://www.who.int/news-room/factsheets/detail/obesity-and-overweight. (Accessed: 11th January 2021)
Grundy, S. M. Metabolic complications of obesity. Endocrine 13, 155–165 (2000).
Garrow, J. S. Obesity and related diseases. Obes. Relat. Dis. (1988).
Bruin, J. E. et al. Treating diet-induced diabetes and obesity with human
embryonic stem cell-derived pancreatic progenitor cells and antidiabetic drugs.
Stem Cell Reports 4, 605–620 (2015).
Kwon, H. & Pessin, J. E. Adipokines mediate inflammation and insulin resistance.
Front. Endocrinol. (Lausanne). 4, 71 (2013).
Guglielmi, V. & Sbraccia, P. Obesity phenotypes: Depot-differences in adipose
tissue and their clinical implications. Eating and Weight Disorders 23, 3–14
(2018).
Al-Sulaiti, H., S. Dömling, A. & A. Elrayess, M. Mediators of Impaired
Adipogenesis in Obesity-Associated Insulin Resistance and T2DM. in Adipose
Tissue - An Update (IntechOpen, 2019). doi:10.5772/intechopen.88746
Cheng, L. et al. Brown and beige adipose tissue: a novel therapeutic strategy for

84

117.

118.

119.
120.

121.
122.
123.
124.
125.
126.
127.
128.

129.

130.

131.

132.

133.

134.

obesity and type 2 diabetes mellitus. Adipocyte 10, 48–65 (2021).
Marcadenti, A. & de Abreu-Silva, E. O. Different adipose tissue depots: Metabolic
implications and effects of surgical removal. Endocrinol. y Nutr. (English Ed. 62,
458–464 (2015).
Villarroya, F., Cereijo, R., Gavaldà-Navarro, A., Villarroya, J. & Giralt, M.
Inflammation of brown/beige adipose tissues in obesity and metabolic disease. J.
Intern. Med. 284, 492–504 (2018).
Bagchi, D. P. & Macdougald, O. A. Identification and dissection of diverse mouse
adipose depots. J. Vis. Exp. 2019, (2019).
Chusyd, D. E., Wang, D., Huffman, D. M. & Nagy, T. R. Relationships between
Rodent White Adipose Fat Pads and Human White Adipose Fat Depots. Frontiers
in Nutrition 3, (2016).
Farmer, S. R. Regulation of PPARγ activity during adipogenesis. Int. J. Obes. 29,
S13–S16 (2005).
Gregoire, F. M., Smas, C. M. & Sul, H. S. Understanding adipocyte
differentiation. Physiological Reviews 78, 783–809 (1998).
Payne, V. A. et al. C/EBP transcription factors regulate SREBP1c gene expression
during adipogenesis. Biochem. J. 425, 215–223 (2010).
Youn, D. Y., Xiaoli, A. M., Pessin, J. E. & Yang, F. Regulation of metabolism by
the Mediator complex. Biophys. Reports 2, 69–77 (2016).
Harper, T. M. & Taatjes, D. J. The complex structure and function of Mediator. J.
Biol. Chem. jbc.R117.794438 (2017). doi:10.1074/jbc.R117.794438
Conaway, J. W. et al. The mammalian Mediator complex. in FEBS Letters 579,
904–908 (Elsevier, 2005).
Esnault, C. et al. Mediator-dependent recruitment of TFIIH modules in
preinitiation complex. Mol. Cell 31, 337–46 (2008).
Flanagan, P. M., Kelleher, R. J., Sayre, M. H., Tschochner, H. & Kornberg, R. D.
A mediator required for activation of RNA polymerase II transcription in vitro.
Nature 350, 436–438 (1991).
Malik, S., Barrero, M. J. & Jones, T. Identification of a regulator of transcription
elongation as an accessory factor for the human Mediator coactivator. Pnas 104,
6182–6187 (2007).
Taatjes, D. J., Näär, A. M., Andel, F., Nogales, E. & Tjian, R. Structure, function,
and activator-induced conformations of the CRSP coactivator. Science (80-. ). 295,
1058–1062 (2002).
Baek, H. J., Malik, S., Qin, J. & Roeder, R. G. Requirement of TRAP/mediator for
both activator-independent and activator-dependent transcription in conjunction
with TFIID-associated TAF(II)s. Mol. Cell. Biol. 22, 2842–52 (2002).
Dannappel, M. V., Sooraj, D., Loh, J. J. & Firestein, R. Molecular and in vivo
Functions of the CDK8 and CDK19 Kinase Modules. Front. Cell Dev. Biol. 6, 171
(2019).
Leonard, M. & Zhang, X. Estrogen receptor coactivator Mediator Subunit 1
(MED1) as a tissue-specific therapeutic target in breast cancer. Journal of Zhejiang
University: Science B 20, 381–390 (2019).
Weber, H. & Garabedian, M. J. The mediator complex in genomic and nongenomic signaling in cancer. Steroids 133, 8–14 (2018).

85
135. Ranjan, A. & Ansari, S. A. Therapeutic potential of Mediator complex subunits in
metabolic diseases. Biochimie 144, 41–49 (2018).
136. Yeon Youn, D., Xiaoli, A. M., Kwon, H., Yang, F. & Pessin, J. E. The subunit
assembly state of the Mediator complex is nutrient-regulated and is dysregulated in
a genetic model of insulin resistance and obesity. doi:10.1074/jbc.RA119.007850
137. Hengartner, C. J. et al. Temporal regulation of RNA polymerase II by Srb10 and
Kin28 cyclin-dependent kinases. Mol. Cell 2, 43–53 (1998).
138. Poss, Z. C., Ebmeier, C. C. & Taatjes, D. J. The Mediator complex and
transcription regulation. Crit. Rev. Biochem. Mol. Biol. 48, 575–608 (2013).
139. Nanbu-Wakao, R. et al. Stimulation of 3T3-L1 adipogenesis by signal transducer
and activator of transcription 5. Mol. Endocrinol. 16, 1565–1576 (2002).
140. Knuesel, M. T., Meyer, K. D., Bernecky, C. & Taatjes, D. J. The human CDK8
subcomplex is a molecular switch that controls Mediator coactivator function.
Genes Dev. (2009). doi:10.1101/gad.1767009
141. Sarjeant, K. & Stephens, J. M. Adipogenesis. Cold Spring Harb. Perspect. Biol. 4,
(2012).
142. Otto, T. C. & Lane, M. D. Adipose development: From stem cell to adipocyte.
Critical Reviews in Biochemistry and Molecular Biology 40, 229–242 (2005).
143. Zhang, K. et al. Molecular Mechanism of Stem Cell Differentiation into
Adipocytes and Adipocyte Differentiation of Malignant Tumor. Stem Cells
International 2020, (2020).
144. Rosen, E. D. et al. C/EBPα induces adipogenesis through PPARγ: A unified
pathway. Genes Dev. 16, 22–26 (2002).
145. Kim, J. B. & Spiegelman, B. M. ADD1/SREBP1 promotes adipocyte
differentiation and gene expression linked to fatty acid metabolism. Genes Dev.
10, 1096–1107 (1996).
146. Amoasii, L. et al. A MED13-dependent skeletal muscle gene program controls
systemic glucose homeostasis and hepatic metabolism. Genes Dev. 30, 434–446
(2016).
147. Baskin, K. K. et al. MED 13‐dependent signaling from the heart confers leanness
by enhancing metabolism in adipose tissue and liver . EMBO Mol. Med. 6, 1610–
1621 (2014).
148. Miller, C. et al. Mediator phosphorylation prevents stress response transcription
during non-stress conditions. J. Biol. Chem. 287, 44017–44026 (2012).
149. Schiano, C., Casamassimi, A., Vietri, M. T., Rienzo, M. & Napoli, C. The roles of
mediator complex in cardiovascular diseases. Biochimica et Biophysica Acta Gene Regulatory Mechanisms 1839, 444–451 (2014).
150. Mittal, A. et al. COVID-19 pandemic: Insights into structure, function, and hACE2
receptor recognition by SARS-CoV-2. PLoS pathogens 16, e1008762 (2020).
151. WHO Coronavirus (COVID-19) Dashboard | WHO Coronavirus (COVID-19)
Dashboard With Vaccination Data. Available at: https://covid19.who.int/.
(Accessed: 26th May 2021)
152. Popkin, B. M. et al. Individuals with obesity and COVID-19: A global perspective
on the epidemiology and biological relationships. Obes. Rev. 21, (2020).
153. Wadman, M. Why COVID-19 is more deadly in people with obesity—even if
they’re young. Science (80-. ). (2020). doi:10.1126/science.abe7010

86
154. Mousavizadeh, L. & Ghasemi, S. Genotype and phenotype of COVID-19: Their
roles in pathogenesis. Journal of Microbiology, Immunology and Infection 54,
159–163 (2020).
155. Chu, D. K. W. et al. Molecular Diagnosis of a Novel Coronavirus (2019-nCoV)
Causing an Outbreak of Pneumonia. Clin. Chem. 66, 549–555 (2020).
156. Lu, X. et al. US CDC real-time reverse transcription PCR panel for detection of
severe acute respiratory syndrome Coronavirus 2. Emerg. Infect. Dis. 26, 1654–
1665 (2020).
157. Falasca, F. et al. Detection of SARS-COV N2 Gene: Very low amounts of viral
RNA or false positive? J. Clin. Virol. 133, 104660 (2020).
158. Grant, P. R. et al. Detection of SARS Coronavirus in Plasma by Real-Time RTPCR. N. Engl. J. Med. 349, 2468–2469 (2003).
159. Daughton, C. G. Wastewater surveillance for population-wide Covid-19: The
present and future. Science of the Total Environment 736, 139631 (2020).
160. Larsen, D. A. & Wigginton, K. R. Tracking COVID-19 with wastewater. Nature
Biotechnology 38, 1151–1153 (2020).
161. Gallardo-Escárate, C. et al. The wastewater microbiome: A novel insight for
COVID-19 surveillance. Sci. Total Environ. 764, 142867 (2021).
162. Weidhaas, J. et al. Correlation of SARS-CoV-2 RNA in wastewater with COVID-19
disease burden in sewersheds 1.

